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ABSTRACT 
Role of Heme in the Folding and Assembly of Globins 
by 
David Sean Culbertson 
Globins constitute a superfamily of proteins that bind a heme cofactor and have 
diverse physiological roles, ranging from oxygen management to nitric oxide scavenging 
to gas sensing. Sperm whale myoglobin (Mb) has remained the key system for a wide 
variety of biophysical investigations of globin function and structure. It possesses the 
conserved and well-characterized 3-on-3 helical fold, which produces a hydrophobic 
pocket for heme binding and exogenous ligand coordination. Upon removal of the heme 
prosthetic group, the protein loses -40% of its native secondary structure but still serves 
as a model apo-protein with high helical content for unfolding studies. At least one on-
pathway apoMb intermediate is populated kinetically during folding or at eqUilibrium 
during acid, urea, or GuHCl-induced denaturation. In contrast, much less is known about 
the folding and assembly of the holoMb, and how heme confers resistance to 
denaturation. It is presumed that in vivo, oxidation of the heme iron from the ferrous to 
the ferric state precedes denaturation; however the detailed mechanism for the unfolding 
of the ferric holoprotein has remained enigmatic. The work presented defines the role of 
heme quantatively in the folding and assembly of Mb and possibly for the assembly of 
globins in general. We have demonstrated that ferric holoMb unfolds via a hemin-bound 
intermediate state, which has the characteristics of a reversible hemichrome species that 
is also on the pathway to assembly back to the holoprotein. Similar hemichrome 
intermediates are observed during unfolding of adult human HbA. The formation of this 
hemichrome state is very relevant to the biology of erythropoiesis, hemoglobin 
degradation and the formation of Heinz bodies in circulating red blood cells. We have 
also tested our methodology using a simpler monomeric hemoglobin from Cerebratulus 
lacteus that possesses low stability and does not populate an intermediate capable of 
binding heme. All of these results have general implications in biophysics for how 
cofactor-containing proteins fold, in biology for the understanding of erythropoiesis (i.e., 
in vivo hemoglobin assembly), and in biotechnology for the understanding of how to 
optimize heterologous expression yields of recombinant holo heme proteins in E. coli for 
either research or commercial purposes. 
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PREFACE 
This thesis work was started under the supervision of Dr. Pernilla Wittung-
Stafshede who had some experience with myoglobin and electron-transfer triggered 
folding of redox-proteins during her postdoctoral work under Dr. Harry B. Gray. 
The main question was to answer whether holomyoglobin unfolds by a two or 
three-state mechanism and whether the intermediate state of apomyoglobin can 
specifically bind heme. After numerous attempts to resolve the key questions using 
isothermal titration calorimetry, stopped-flow induced refolding, and simple analyses of 
equilibrium unfolding experiments, it became clear that a more systematic approach 
using both mutant and wild-type Mbs was needed. 
Dr. Pernilla Wittung-Stafshede left Rice University to return to Sweden and Dr. 
John S. Olson who had been the chair of my thesis committee and is an expert in the 
globin field generously accepted me into his laboratory. We soon discovered that the apo 
and holo forms of myoglobin could be compared with a holistic mechanistic approach 
and that the affinities of the fully folded apo state (N) and partially unfolded apo state (I) 
for hemin could be obtained quantatively. This approach has proven to be a successful 
and powerful tool in linking stability of holo protein with stability of the apo protein and 
cofactor affinity. 
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Chapter 1 
Introduction and background 
This chapter is adapted from: 
Culbertson, D.S., and Olson, J.S. (2010). Folding and Assembly of Myoglobins and 
Hemoglobins. In Protein Folding and Metal Ions: Mechanisms, Biology, and 
Disease, P. Wittung-Stafshede, and C.M. Gomes, eds. (Taylor and Francis, Inc.). 
pp.97-122. 
Culbertson, D.S., and Olson, J.S. (2010). Role of heme in the unfolding and assembly of 
myoglobin. Biochemistry 49, 6052-6063. 
1.1. Protein folding and its importance 
Proteins are key to any form of life and are the workhorses of cells. They 
participate in every aspect of what makes life possible, including the structural scaffold of 
the cell, signaling pathways, cell adhesion, immune responses, enzymatic catalysis of 
biochemical reactions, and as enzymes are involved in almost every part of cell 
metabolism. Proteins are made of long chains of amino acids that fold up into a unique 
configuration that is responsible for their biological function. The information contained 
in DNA is transcribed into RNA, which is later translated by ribosomes using a pool of 
20 different amino acids that differ by size, charge, hydrophobicity, geometry, and 
polarity. It is the unique amino acid sequence and length that provide their unique 
function, which can vary from transporting ions through a channel in a membrane to 
suppressing tumors. 
In 1969, Cyrus Levinthal postulated the paradox that if proteins were to 
sequentially sample every possible conformation to attain the final (native) structure, the 
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folding process of proteins, even of small sizes, would require an astronomical amount of 
time, regardless whether each conformation would be sampled every nanosecond (e.g., 
_10128 years for a 100 amino acid chain) (Zwanzig et al., 1992). The fact that proteins 
fold spontaneously (i.e., microseconds to seconds) led to the conclusion that proteins fold 
in a directed process, dictated by energetic constraints, which later resulted in the 
theoretical representation of the folding process using a funnel-like energy landscape. In 
1972, Christian Anfinsen received the Nobel Prize in Chemistry for demonstrating, using 
ribonuclease, that all the information required for proper folding to reach an energetic and 
kinetically accessible minimum is contained within the protein primary sequence 
(Anfinsen, 1972, 1973). 
The relationship between structure and pathogenic activity of proteins is a subject 
of great interest. A growing number of diseases appear to be the result of misfolded 
proteins (Iannuzzi et al., 2007; Kelly, 1998; Sigurdsson et at., 2002; Westermark et at., 
2002). Diseases such as Huntington's, Tay-Sachs, Alzheimer's, Parkinson's, Creutzfeldt-
Jacob as well as cystic fibrosis, phenylketonuria, Marfan syndrome, scurvy, 
hypercholesterolaemia, and sickle cell anemia have been linked to specific proteins 
misfolding in the ER or cytosol (Dobson, 2002). As a result, scientists are trying to 
understand how proteins fold to find cures for both genetic and infectious diseases by 
rescuing a protein's function or alleviating pathologies triggered by protein misfolding. 
Proper folding is required for proper activity; yet, more than 30% of proteins in 
cells require a cofactor to function (Gray, 2003). The addition of a cofactor to the folding 
process adds another level of complexity to the question of how proteins assemble to 
become active. Cofactors may bind early on, during, or after folding, and a quantitative 
3 
understanding of the role of the cofactor in assembly of their respective proteins is 
required. Remarkably, the folding and assembly of globins, which contain the heme 
cofactor, remained poorly understood despite the large amount of literature on the 
biophysical properties of hemoglobins and myoglobins. 
1.2. Globins in biology 
Human hemoglobin (Hb) was first identified in 1840 by Hiinefeld (1840) as the 
main pigment in blood, and its primordial role in oxygen transport was later demonstrated 
by the works of Stokes and Hoppe-Seyler (Severinghaus and Astrup, 1986). Myoglobin 
(Mb) was later discovered in striated muscle cells and was assigned a role for storing O2 , 
captured during blood flow and released during muscle contractions (Wittenberg, 1970; 
Wittenberg and Wittenberg, 2003). Globins have now been discovered in almost all 
known organisms from all kingdoms of life (Fig. 1.1) (Burmester et al., 2004; Kundu et 
al., 2003; Vinogradov et al., 2007). Examination of the human genome over the past 
decade led to the discovery of two additional human globins, neuroglobin and cytoglobin 
(Fig. 1.3). 
The diverse functions of glob ins 
Globins have diverse functions ranging from gas sensing to NO scavenging to O2 
management (Fig. 1.1). The various functions of mammalian Mb and Hb are discussed 
later in depth. It has been speculated that the animal neuroglobins and cytoglobins 
provide protection against apoptosis, and facilitate regeneration in neuronal cells and 
myocytes during hypoxic or ischemic conditions (Brittain et al., 2010; Burmester et al., 
4 
2007; Fordel et aI., 2004; Fordel et aI., 2007; Hankeln et aI., 2005; Schmidt et aI., 2004; 
Singh et aI., 2009). 
There are aIso a wide variety of invertebrate animal hemoglobins, which range 
from smail mini-globin monomers (e.g., 109 amino acid globin in Cerebratulus lacteus 
(Pesce et aI., 2002; Salter et aI., 2008» to high molecular weight globin aggregates (e.g., 
the erythrocruorins found in extracellular spaces of polychete and annelid worms (Strand 
et aI., 2004; Vinogradov et aI., 1977». Most of these globins are involved in O2 
scavenging or storage and transport. 
Diverse Globin Occurrence and Functions: 
Multi-domain 
flavoHbs 
Protog lob ns 
&GCS 
Truncated 
(2/2) Globins 
SDg/obins(3f3) 
" 
..... 
...• 
NO Scavenging 
NO +Hb.0 2- metHb + N03-
.. ' 
11 Syn trHb(l) 
(Myc trHbN) 
O2 storage, 
transport, and 
scavenging 
Figure 1.1. The globin family in biology. The functions are depicted when known in red, green, and blue. 
The following structures were built in ribbons with PyMol from the PDB entries: 1 hho for human HbA 
(HuHBA), lmgm for sperm whale Mh, lbin for soybean Leghemoglobin (Lba(soy)), Id8u for non-
symbitiotic rice Hb, 2hzl for Synechocystis Hb (Syn trHb(I)), lux8 for Bacillus anthracis trHb (Bs 
trHb(II)), I or4 for Bacillus subtilis HemAT, I gvh for E. coli flavoHb (EcFHb(hmp)), I vhb for Vitreoscilla 
stercoraria VHb, lash for Ascaris Hb (AscHb), Ikr7 for Cerebratulus lacteus hemoglobin (CerHb). 
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SeveraI classes of single domain globins are found ubiquitously in plants, the 
most common, being are non-symbiotic, hexacoordinate hemoglobins, which were first 
discovered in rice and Arabidopsis thaliana (Arredondo-Peter et aI., 1997; Kundu et aI., 
2003; Trevaskis et aI., 1997). The exact functions of the hexacoordinate plant Hbs remain 
unclear but these proteins are thought to be a part of an NO/nitrate cycle that facilitates 
anaerobic glycolysis in response to hypoxic stress (Dordas, 2009; Dordas et al., 2(03). 
Leghemoglobins evolved from the class 1 non-symbiotic hemoglobins to have a Mb-like 
function in the root nodules of leguminous plants, where they serve to lower the free 
concentration of O2 to :s 0.1 pM but still facilitate its diffusion to the nitrogen fixing 
bacteria (Appleby, 1984; Hoy et aI., 2007). 
The globin superfamily also includes multidomain bacterial and fungaI 
flavohemoglobins which are fusion proteins consisting of an N-terminaI globin domain 
and a C-terminaI flavoprotein ferredoxin:NADP+ reductase domain. Flavohemoglobins 
are presumed to catalyze NADHl02 driven dioxygenation as part of a defense mechanism 
against host-induced nitrosative stress (Gardner et aI., 2000; Ullmann et aI., 2004). 
Globins from prokaryotes such as Aquifex aeolicus and Bacillus anthracis are 
presumed to function as 02-scavengers, possessing very high oxygen affinities; however, 
these ideas are speculative (Giangiacomo et aI., 2005; Miranda et al., 2(05). On the other 
hand, HemA T found in Bacillus subtilis has been shown to be a heme-based aerotactic 
transducer and functions as a gas sensor (Hou et aI., 2000; Zhang et aI., 2005). 
Structure of glob ins 
The basic globin fold consists of several a-helices that are arranged in a pseudo 
sphericaI shape and form a pocket for the active site, which binds a heme group. Globins 
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can be categorized into four groups: (1) protoglobins with more than 8 a helices, (2) 
truncated 2-on-2 helical Hbs, (3) single domain 3-on-3 helical globins (often with two 
other short helices), and (4) mUltiple domain 3/3 helical globins which contain another 
domain involved in redox reactions or other activities, including protein kinases and 
DNA binding. Mammalian Mbs, neuroglobins, cytoglobins, and the Hb subunits (a, p, b, 
and y) are classical single domain 3/3 globins (Figs. 1.1-3) with similar folds containing 8 
a helices, labeled A to H, with the exception that the a subunit of Hb has only 7 helices 
and lacks the D helix (Dickerson and Geis, 1983). The characteristic fold is crucial for 
the formation of a hydrophobic pocket for heme binding (Fig. 1.2-3). Helices C and D are 
short, variable in length, and located between the longer B and E helices, forming one 
side of the heme pocket. Sperm whale (sw) Mb has all 8 a helices and serves as the 
model for the structure and function of all single domain globins. 
C-terminus 
Figure 1.2. Basic helical structure of single domain globins with 3/3 helix fold as found in mammalian 
Mb and Hb subunits. The proximal and distal histidines coordinate heme (dark sticks) , and helices A to 
H are labeled as well as both termini . Actual figure depicts the crystal structure of native sw metMb. 
The image was created using PyMol and PDB entry: Ijp6. 
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Figure 1.3. Crystal structures of human cytoglobin and neuroglobin. Cytoglobin (left, PDB entry: 2dc3) 
and neuroglobin (right, PDB entry: 10j6) are shown in ribbons. The proximal histidines and heme cofactors 
are shown in gray sticks. Cytoglobin has a C-tenninus extension. Images created using PyMol. 
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Heme coordination in globins 
The equatorial d-orbitals of the heme-iron coordinate the four tetrapyrrole 
nitrogens of the pyrroles rings in the equatorial plane, and the axial positions are 
coordinated to the imidazole side chain of the proximal histidine on the F helix position 8 
(F8) and an external 6th ligand when present in the distal portion of the heme pocket 
(Figs. 1.2 and 1.4). In erythrocytes and myocytes, the heme iron is > 95% reduced (Fe", 
ferrous) and is either coordinated to O2 or pentacoordinate without a sixth ligand (deoxy). 
In vitro, ferrous Mbs and Hbs can bind °2 , eo, NO, or alkyl isocyanides whereas the 
ferric or met forms (Fern) can bind H20, eN·, N3-, F, seN-, N02-, or NO (Antonini and 
Brunori, 1971). The heme-iron may also adopt an oxoferryl FeN state after oxidation by 
hydrogen peroxide, providing peroxidatic activity to globins (Reeder and Wilson, 2(05). 
Binding of ligands is modulated by four factors: the redox state of the heme-iron, steric 
access to the iron atom on the distal side of the heme group, ease of in-plane movement 
of the Fe-proximal imidazole complex, and preferential electrostatic interactions with 
bound O2 and NO (Olson and Phillips, 1997). 
Factors governing the stability of glob ins 
Figure 1.4. Stick representation of heme 
coordination in sperm whale 
oxymyoglobin. The heme is coordinated 
by the proximal histidine His93 (lower) 
and the distal histidine His64 (upper). 
The dioxygen is shown in red sticks with 
the hydrogen bond to the nitrogen of the 
imidazole ring of H64 shown as a blue 
dashed line. Image created using PyMol 
and PBD entry: 1mbo. 
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The presence of heme in globins confers enhanced resistance to denaturation 
induced by chemical and thermal perturbations (Hargrove and Olson, 1996; Landfried et 
al., 2007). Oxidation of Mbs and ~s to the ferric form disables their capacity to bind O2 
until reconversion to the ferrous forms by intracellular reductases (Xu et aI., 1992). The 
rate of heme loss from ferrous Mb is at least 50 to 100 times slower than that from the 
ferric form, and holo-globin unfolding does not occur readily at pH values ~ 7.0 until the 
heme group is lost (Hargrove et aI., 1996b). Thus, under physiological conditions, auto-
oxidation almost certainly precedes denaturation. 
Some globins have evolved to be able to retain functionality under demanding 
conditions and need to be resistant to oxidation, heme loss, and denaturation. Sperm 
whales (Physeter catodon) , as with other marine mammals that undergo extended periods 
of apnea when deep diving, possess higher skeletal muscle Mb concentration to increase 
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O2 delivery capacity (Kooyman and Ponganis, 1998). The apo-forms of these Mbs 
display overall folding constants 20 to 100 times greater than their terrestrial mammalian 
orthologs, making them much easier to study in terms of identifying stable intermediates 
(Scott et al., 2000). 
Oligomerization enhances the stability of proteins both by the strength of the new 
subunit interfaces and by the multiplication factor for the individual stabilities. For 
example, the folding constant for an individual subunit is taken to the fourth power when 
calculating the overall stability of a homo-tetramer as shown in Equation 1.1 below: 
(l.1) 
This effect accounts for the markedly enhanced resistance of the human Hb tetramer to 
denaturation when Hb subunits are assembly into tetramers. This resistance is strongly 
dependent on protein concentration, with disassembly being favored at low 
concentrations (Antonini and Brunori, 1971; Bunn, 1987; Hargrove et al., 1997). In 
erythrocytes, tetrameric Hb is highly concentrated and present at -20 mM on a per heme 
basis. At these levels, tetrameric human Hb is highly resistant to dissociation into dimers 
and monomers, the fractions of which are extremely small. Organisms that use 
extracellular globins for O2 transport have even larger molecular weights with higher 
degrees of oligomerization. The giant hemoglobin from Lumbricus terrestris (Fig. 1.5) is 
strongly resistant to denaturation and is assembled into a giant Hb complex composed of 
144 subunits coupled to a central linker protein scaffold with a total molecular weight of 
-3.6 MDa (Strand et al., 2004). 
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100A 
Figure 1.5. Structure of Lumbricus terrestris erythrocruorin. LEFT: one of the twelve globin dodecamers . 
The globins subunits are shown in cartoon and the heme cofactors are shown in dark gray sticks. Image 
created using PyMol and PBD entry: lx9f. RIGHT: entire erythrocruorin protein with 144 globin subunits 
(purple) arranged around a central scaffold (cyan and orange). Image adapted from (Royer et aI. , 2000) . 
1.3. Sperm whale myoglobin: the classic globin system 
The biological role ofMb 
A requirement for O2 storage and release by Mb is unclear as knock out studies in 
mice demonstrate normal whole animal phenotypes under basal physiological conditions. 
The knock-out mice show adaptation to hypoxic stress as seen by increased cardiac 
capillary density, coronary flow, and blood Hb content (Garry et aI., 1998; Schlieper et 
aI., 2004). In addition to the role linked to oxygen storage and release during muscle 
contraction, Mb has been suggested to playa role in nitric oxide (NO) scavenging 
(Brown, 2003; Eich et al., 1996; Flogel et aI., 2001; Wittenberg and Wittenberg, 2003) 
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and removal of reactive oxygen species (Ordway and Garry, 2004), and these functions 
appear to contribute to endurance and cardiac function in mice (Merx et al., 2(05). 
Furthermore, there appears to be a cycle in which a low oxygen tension in tissues 
provokes a change of Mb roles in relation to NO: in normoxic conditions Mb scavenges 
NO, but may help generate NO under hypoxic conditions (Rassaf et al., 2007). However, 
this latter role remains controversial. 
For a long time it has been known that Mb content in human skeletal muscles 
varies according to oxygen levels (Reynafarje, 1962a, b). In addition, during periods of 
hypoxia-induced erythropoiesis, Mb expression has been found to be down regulated in 
human skeletal muscles to allow heme to be diverted to increased erythrocyte formation 
(Robach et al., 2007). 
Pathoplwiologies linked to Mb 
To date, no genetic myoglobinopathies have been reported but four asymptomatic, 
single mutation Mb variants have been identified in humans (i.e., D54K, K133N, R139Q, 
and R139W) (Romero-Herrera and Lehmann, 1974). The only known Mb-linked 
pathologies are rhabdomyolysis and myoglobinuria, which usually occur concurrently in 
patients that have received physical (e.g., injury) or chemical (e.g., alcohol or drug abuse) 
trauma or suffer from organ failure (Chatzizisis et al., 2008; Daher Ede et al., 2005; 
Knochel, 1993; Slater and Mullins, 1998). Rhabdomyolysis (rapid breakdown of muscle 
fibers) and myoglobinuria (presence of Mb in urine) are responsible for -5% of acute 
renal failure deaths in the US (Zager, 1996). Following trauma, damaged muscle fibers 
can release large quantities of Mb (among other cytosolic proteins) into the bloodstream, 
which are normally filtered through the kidneys and eliminated. Severe trauma may lead 
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to renal necrosis and renal failure by obstruction of renal tubules caused by accumulation 
of metMb and its nephrotoxic breakdown products, which cause significant oxidative 
stress (Braun et aI., 1970; Reeder, 2010). 
Current understanding ofthe in vivo assembly ofMb 
Synthesis of Mb involves expression of the apoMb polypeptide from a single gene 
and production of the heme cofactor. In vitro, apoMb folds properly without heme and 
remains relatively stable, although amyloid fibrils have been discovered after long 
incubation at room temperature (Fandrich et al., 2001; Hughson et al., 1990; Iannuzzi et 
al., 2007). In contrast, fibril formation does not occur with holoMb (Regis et al., 2005), 
and fibrillization of amyloidogenic apoMb (Fandrich et al., 2001) as well as induced 
toxicity appear to be inhibited by heme binding (Iannuzzi et al., 2007). Early interactions 
of heme during the initial folding of the Mb polypeptide might be a requirement in vivo 
for avoiding misfolding, and formation of amyloid fibrils at 37°C. Despite the lack of 
known Mb misfolding diseases (Eakin et al., 2002), it is possible that some diseases do 
involve Mb aggregates, as is observed for inclusion body myositis, which occurs due to 
trauma or exposure to toxic chemical oxidants (Needham and Mastaglia, 2007). 
Structure ofapoMb 
Although ultra-high resolution structures of holoMb from several species have 
been determined by X-ray crystallography (Birnbaum et al., 1994; Evans and Brayer, 
1990; Kendrew et aI., 1958; Schreiter et al., 2007; Scouloudi and Baker, 1978; Smerdon 
et al., 1990), the crystal structure of "native" apoMb has not been determined to date. 
ApoMb can be produced in vitro by extraction of the heme into organic solvents at low 
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pH (Ascoli et al., 1981). When samples of apoMb are neutralized, the resultant protein 
has lost about a third of its helicity as measured by its CD spectrum, but the remaining 
tertiary and secondary structures appear to be similar to those found in the holo-form. 
High resolution NMR experiments indicate loss of structure in the F helix, the EF and FG 
loops, the N-terminal portions of the G helix, and the C-terminus of the H helix, whereas 
the A, B, C, 0, E, and most of the G and H helices appear intact (Eliezer and Wright, 
1996; Eliezer et al., 1998; Lecomte et al., 1999). ApoMb also loses compactness as 
measured by small angle X-ray scattering (Nishii et al., 1994). 
Equilibrium analysis of the apoMb unfolding mechanism 
The unfolding of apoMb has been extensively studied in vitro. The existence of a 
folding intermediate was first proposed in 1976 (Balestrieri et al., 1976), building on 
previous fluorescence experiments (Kirby and Steiner, 1970) which led to the analysis of 
apoMb unfolding using a three-state unfolding mechanism (Barrick and Baldwin, 1993b; 
Hargrove et al., 1994a; Ramsay et al., 1995). The acid and urea-induced intermediates 
have been structurally characterized by circular dichroism (CD), site-directed 
mutagenesis, and hydrogen exchange NMR experiments. The results suggest that the A, 
G, H, and part of the B helices remain folded and docked to each other, forming a 
molten-globule hydrophobic core, whereas the other regions of the protein, including 
most of the heme pocket, are highly disordered and flexible (Eliezer et al., 2000; Eliezer 
et al., 1998; Grlko et aI., 1988; Hughson and Baldwin, 1989; Hughson et al., 1991; 
Hughson et al., 1990; Jennings and Wright, 1993; Nishimura et al., 2003). 
The intermediate (I) has been shown to possess higher fluorescence than either the 
original native or unfolded states. The emission peak for this 1 state is at a wavelength in 
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between those for the folded and unfolded states when the intennediate is induced by acid 
or GuHCI (Ramsayet al., 1995). One theory is that partial unfolding to the I state causes 
an increase in fluorescence of Trp7 due to an apolar collapse of EF comer onto the G and 
H helices, which moves Lys79 or Met131 away from the indole ring and buries it in a 
more hydrophobic environment (Ballew et al., 1996; Hargrove et aI., 1994a; Irace et al., 
1981; Kirby and Steiner, 1970; Tcherkasskaya et al., 2000a; Tcherkasskaya et al., 2000b). 
Another theory is that hyperfluorescence may be caused by enhanced flexibility of the 
fluorophores in the intennediate state (Ervin et al., 2002). 
The three-state N-to-I-to-U equilibrium-unfolding path is easily observed under 
acid and GuHCI denaturation conditions (Barrick and Baldwin, 1993a; Barrick et al., 
1994; Griko et al., 1988; Nishii et al., 1995) but is less readily characterized when 
unfolding is induced by urea due to higher fluorescence of the unfolded state (Barrick and 
Baldwin, 1993b; Baryshnikova et al., 2(05). At low pH, sw apoMb may populate two 
distinct intennediates (i.e., Ia and Ib) that differ by additional secondary structure in helix 
B (Jamin and Baldwin, 1998; Loh et al., 1995); however only one equilibrium state 
intennediate has been reported using GuHCI and urea as denaturants at neutral pH. 
The kinetics ofapoMb folding 
The folding and unfolding rates of apoMb have also been extensively studied. A 
kinetic folding intennediate of apoMb was first described in 1993 by Wright and 
colleagues who reported a burst phase intennediate with helices A, G, and H fonned 
within the dead time (few ms) of the stopped-flow mixing device, which was followed by 
complete folding to the native apo-state several seconds later (pH 6.1, 5 0c) (Jennings 
and Wright, 1993). The initial submillisecond collapse to the intennediate corresponded 
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to an initial gain of a third of the final secondary structure (far-UV CD) and half of the 
change in radius of gyration (X-ray scattering) for a pH jump from 1.2 to 6 (Uzawa et al., 
2004). These early microsecond CD and fluorescence changes appear to correspond to 
formation of the A, G, and H helix core (Ballew et al., 1996). Thus, the intermediates 
observed by equilibrium-unfolding and kinetic-refolding experiments are believed to 
possess very similar structures. The major exceptions are that the E helix, which plays no 
apparent role in the eqUilibrium intermediate, appears to stabilize the transient folding 
intermediate states by docking with the hydrophobic core of A, G, and H helices and that 
non-native interactions between theses helices are formed in the kinetic I states, which 
must be resolved before final folding can occur (Nishimura et al., 2006). These 
conclusions were also supported by the observations that the H64F and H64L mutations 
stabilize the I state (Smith, 2003). In most kinetic experiments, two kinetically trapped 
intermediates, denoted as la and Ib' are commonly observed and may have structures 
similar to the two intermediates found in steady-state experiments with urea and pH 
(Jamin and Baldwin, 1998; Loh et aI., 1995). Thus, the refolding of apoMb may involve a 
three-step process with U to la' la to Ib and Ib to N phases, having half-times of 
approximately 5 J.l.S, 30 ms and 0.5 s, respectively (Jamin, 2005; Jamin and Baldwin, 
1998; Uzawa et al., 2004); however these kinetic intermediates are sensitive to 
experimental conditions, and it is difficult to establish their relevance to the equilibrium 
folding mechanism. 
Folding ofholoMb 
The mechanism of holoMb unfolding has only been addressed in a few studies, 
and until our work, most analyses were semi-empirical and assumed an apparent two-
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state equilibrium- and/or kinetic mechanism (Hargrove et al .• 1994a; Hargrove and 
Olson. 1996; Hargrove et al .• 1996b; Moczygemba et al .• 2000; Ramos et al .• 1999; Regis 
et al .• 2005; Wittung-Stafshede et al .• 1998). The resistance of holoMb to unfolding 
appears to be determined primarily by heme affinity (Hargrove et al .• 1996b). and 
therefore. redox state and bound ligands are major factors influencing stability (Hargrove 
and Olson. 1996). For example. the reduced. unliganded form of Mb (deoxyMb-Fe") is 
much more resistant to chemical denaturation than the oxidized form (metMb-Feill). most 
likely due to the enhanced heme affinity (Hargrove and Olson. 1996). A quantitative 
analysis of the observed unfolding curves requires a detailed mechanism that accounts for 
the fate of the dissociated heme. i.e., whether it self-associates. binds to unfolded and 
intermediate states. or participates in all of these processes. 
The aQinits offolded apoMh for heme 
The heme affinity of all globins is too high to measure directly in eqUilibrium 
titrations. Estimates of the equilibrium association constant can be calculated from the 
ratio of heme association and dissociation rate constants. and the value for hemin binding 
to sw apoMb is KH ::::: 1014 M·I (Hargrove et al .• 1996a). Three major factors appear to be 
responsible for this high affinity: (1) nonspecific hydrophobic interactions between the 
porphyrin and the hydrophobic pocket (105-107 Mol). (2) covalent bond formation 
between the ferric iron and the proximal His93 (103_104 Mol). and (3) specific interactions 
with conserved amino acids in the heme pocket (103_104 Mol) (Hargrove et al .• 1996b). 
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Rates of heme binding and release 
The first kinetic studies of heme binding to apoMb (and apoHb) were carried out 
in the 1960s (Antonini and Gibson, 1960; Gibson and Antonini, 1960). In most cases, the 
reaction of free heme with apo-globin shows a biphasic time course, with a rapid 
bimolecular phase (k'H ::::: 1 x108 M-Is-I) and slow fIrst order phase, which itself shows 
heterogeneity but little or no dependence on apoprotein concentration. The slow phases 
have been attributed to the dissociation of hemin dimers and perhaps even higher-order 
aggregates (Adams, 1977; Asher et aI., 2009; Brown et al., 1970; de Villiers et al., 2007; 
Hargrove et al., 1996a; Kuzelova et al., 1997), which need to dissociate before binding 
can occur. Using electrospray ionization mass spectrometry, Lee and coworkers (Lee et 
al., 1999) have suggested that hemin aggregates bind to apoMb, producing intermediates 
of holoMb with as many as three hemes attached at one time, although this is probably 
unlikely in the absence of excess hemin, and may be an artifact of the electrospray 
analysis. 
To avoid these problems, most workers have used CO-heme, which is 
monodisperse up to concentrations of 10 JA.M due to presence of a bound ligand (Gibson 
and Antonini, 1960; Hargrove et al., 1996a; Light et al., 1987; Rose and Olson, 1983). 
Dicyano-hemin «CNkheme) has also been used in kinetic binding studies because it is 
completely monodisperse (Brown et al., 1970; Shack and Clark, 1947). However, the 
presence of the two axial ligands creates additional kinetic phases due to dissociation of 
at least one of the cyanides after binding the protein (Chiba et al., 1994; Crespin et al., 
2005; Kawamura-Konishi et al., 1988). 
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1.4. Cerebratulus lacteus hemoglobin: a simpler unfolding system 
Biological role of CerHb 
In 1998, a mini-Hb (109 residue monomer, 12.0 kDa, Fig. 1.6.) was discovered in 
the neuronal tissues of the nemertean worm Cerebratulus lacteus (Vandergon et al., 
1998). The monomeric globin, referred to as CerHb, functions as an O2 storage molecule, 
similar to Mb, for use during periods of hypoxia to anoxia when the worm is burrowing 
deep in sand. In vitro, CerHb can also bind CO and NO with high affinity (Pesce et al., 
2004; Salter et aI., 2008). 
Figure 1.6. Overlay of sw Mb and 
Cerebratulus lacteus hemoglobin 
represented in gray and red ribbons, 
respectively. The A helix, missing in 
CerHb, is shown in dark gray. Figure 
created with PyMol using PDB entries 
lkr7 (CerHb) and Ijp6 (sw Mb). 
Structure of CerHb 
The crystal structure of CerHb was resolved by Pesce and colleagues in 2001 
(Pesce et al., 2001), and shows CerHb to be an ancestor to MbIHb chains (high sequence 
conservation); however, CerHb does not possess an A helix, and parts of the Band H 
helices are truncated (Fig. 1.6). The OlsonIMoen group has characterized ligand binding 
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to CerHb in great detail, generating a library of over 150 different mutants (Pesce et aI., 
2004; Salter et aI., 2008). The very large O2 association rate constant is due to a 
hydrophobic tunnel created by the lack of the N-terminal A helix and a shortened H helix 
(Salter et aI., 2008). Until our work, CerHb had not been characterized in terms of its 
folding mechanism. CerHb is of interest as it lacks the main components of the molten 
globule intermediate in apoMb and, therefore, might be useful as a simple monomeric 
globin model, in which the apoform unfolds by a two-state mechanism. 
1.5. Human hemoglobin: a complex hetero-tetramer 
Biological role ofHb 
Vertebrate Hbs function primarily as dioxygen transporters packaged in red blood 
cells and deliver O2 from the lung alveolar gas spaces to actively respiring striated 
muscles and neuronal tissues. The Hb02 form of these proteins, like Mb02 , also scavenge 
NO by dioxygenating it to nitrate (Brown, 2003; Doherty et aI., 1998; Eich et aI., 1996; 
FIogel et aI., 2001; Merx et aI., 2005; Wittenberg and Wittenberg, 2003). NO produced 
by inducible nitric oxide synthase (iNOS) during inflammation shuts down the TCA 
cycle and electron transport chain of invading pathogens, but is cytotoxic to muscle cells 
(Gardner et aI., 2000; Ullmann et aI., 2004). Thus, the oxyHb present in circulating red 
cells actively detoxifies NO to nitrate during periods of systematic inflammation or 
inhalation of toxic gases. 
Even though Hb has been extensively studied for over a century, little is known 
about the detailed mechanisms involved in Hb folding and assembly during 
erythropoiesis. Hb is the main component in mature erythrocytes and reaches a 
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concentration of -5-5.5 mM on a per tetramer basis or 20-22 mM on a per heme basis 
(Messerschmidt, 2001). Among Hb variants, hemoglobin A (HbA) is the most prevalent 
in human adult erythrocytes (97%) and is composed of 2 a and 2 P subunits (Schechter, 
2008). The P subunits found in HbA are replaced by b and y subunits in Hemoglobin A2 
(HbA2) and fetal hemoglobin (HbF), respectively. 
Structure ofRhA 
The human adult HbA is composed of 2 a and 2 P subunits of 141 and 146 
residues, respectively, that assemble into a hetero-tetramer with two strong interfaces 
(alPI and ~P2) and two weak interfaces (a1P2 and a 2PI) (Fig. 1.7). The subunits when 
assembled into the tetramer possess the characteristic 3-on-3 helix fold (Fig. 1.2), with 7 
and 8 helices present in the a and P subunits respectively, the a subunit lacking the D 
helix. Human HbA exists in two major conformational states: relaxed (R) and tense (T) 
states. The R state has a higher O2 affinity, and in the absence of O2, the R state reverts to 
the more stable T state. The inter-subunit interactions influence O2 binding and vice versa 
resulting in cooperativity. 
Erythropoiesis 
Erythropoiesis is the development of mature red blood cells. Erythrocytes (red 
blood cells) are the primary oxygen cellular carriers of O2 in our body and have been the 
focus of physiological studies since William Harvey's description of the human 
circulating systems in the 1600s (Ebert and Bunn, 1999; Ferreira et al., 2005; Orkin, 
1995; Pang et al., 2005; Zhu and Emerson, 2002). Mature erythrocytes of healthy adults 
are formed from hematopoietic stem cells in the red marrow of large bones in about 
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seven days and are released into circulating blood at a rate of .... 2.4 million per second 
(Sackmann, 1995). The maturation process is very complex and involves the progressive 
loss of organelles (nucleus, mitochondria, lysosomes, and ribosomes), accompanied by 
production of specific proteins, mostly Hb as well as erythropoietin, transferrin receptors, 
glycophorin and spectrin (Ebert and Bunn, 1999; Ferreira et aI., 2005; Orkin, 1995; Pang 
et aI., 2005; Zhu and Emerson, 2002). 
HbA is the major component of mature adult erythrocytes. The synthesis of Hb is 
governed by many mechanisms that ensure that heme, a-, and p-chains are synthesized in 
the correct 4:2:2 ratio, because any imbalance can have severe toxic effects on the red 
cells (Chen, 2007). The levels of heme are critical during erythropoiesis as they also 
regulate gene transcription and translation of the Hb chains (Chen, 2007). For example, 
heme has been shown to regulate the transcriptional factor Bach1 during erythroid 
differentiation (Igarashi and Sun, 2006; Taketani, 2005) as well as translation in erythroid 
precursors by modulating eIF2a kinase activity of heme-regulated inhibitor kinase (HRI) 
to reduce excessive production of globins (Chen, 2007). It has been suggested that 
mammalian cells might contain a pool of free heme, which could serve both precursor 
and regulatory functions (Ponka, 1999; Wagener et aI., 2001). Interestingly, because the 
heme binding affinities of Bach1, heme regulated inhibitor (HRI) and heme oxygenase 
(HO-1) appear to be on the order of 106-7 M-1 (Chen, 2007), the levels of free heme in 
erythrocytes are most likely in the high nanomolar to low micromolar range. 
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Figure 1.7. Crystal structure of adult human oxyHbA. The 2 a and 2 f3 chains are represented in silver and 
gold ribbons, respectively. The four hemes are shown in red sticks bound to the respective proximal and 
distal histidines in blue. Image created using PyMol and PDB entry: 2dnl. 
Erythropoiesis, which involves high level of Hb expression in erythroid 
precursors, is also dependent on the availability of large amounts of heme to avoid 
anemias (i.e., at least 20 mM levels bound to Hb). Interestingly, heme in erythrocytes is 
produced at a rate dependent on the insertion of iron into porphyrin rings by 
ferrochelatase, contrary to non-erythroid cells where the formation of o-aminolevulinic 
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acid is the rate limiting step in heme biosynthesis (Ponka, 1997). The iron requirement in 
erythroid cells is solely provided by transferrin (Hemmaplardh and Morgan, 1974a, b). In 
addition to heme-linked regulation of erythropoiesis, erythropoietin serves as a feedback 
loop to control the amount of synthesized red blood cells according to oxygen demand 
and red blood cell destruction rate (Socolovsky, 2007). In addition, the recently identified 
peptide-hormone hepcidin has been suggested to play a role in the regulation of iron 
recycling and iron balance (Ganz, 2006), which in tum affects Hb production and 
erythropoiesis (Nicolas et al., 2(02). 
Hemoglobinopathies 
Hemoglobin disorders, or hemoglobinopathies, occur due to defects in globin 
structures or gene expression. Any mutation that leads to a change in secondary or 
tertiary structure in one of its subunits can be the cause of pathophysiologies. Among 
several diseases linked to structural changes in Hb, sickle cell anemia is the best 
characterized medically and is due to a single-point mutation (E6V) in the f3-subunit, 
which induces a conformation change of the tetramer (a2f3S 2) and abnormal erythrocyte 
morphology (Bunn and Forget, 1986; Schechter, 2008). 
Synthesis of Hb is strictly regulated and any deviation from the 2:2:4 ratio of 
a:f3:heme can lead to severe cytotoxic effects (Chen, 2(07). Hb in healthy human adults 
is located exclusively in mature erythrocytes circulating in blood plasma where it 
accounts for two thirds of total iron in humans (Stojiljkovic and Perkins-Balding, 2002). 
However, a small amount (5 to 50 mg/l) ofHb is normally present in plasma as a result of 
spontaneous hemolysis and is normally transported back to the liver as dimers bound to 
haptoglobin (Stojiljkovic and Perkins-Balding, 2002). 
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Thalassemias are characterized by an inherited imbalance in expression of HbA 
subunits and can cause anemia-like symptoms in humans (Bank, 2007; Schechter, 2008; 
Yu et al., 2(07). The a- and j3-thalassemias have distinct pathologies that are directly 
linked to which subunit fails to be produced in the proper amount. In a-thalassemia, the 
j3-chains are being produced in excess, which usually produces a less severe anemia than 
in j3-thalassemia where the a-chain is expressed in excess. This difference is due to two 
factors: first, a-subunits are encoded by two genes (four alleles) whereas only one gene 
(two alleles) encodes the j3-chains, so that loss of one a-gene is not as severe as the loss 
of one j3-gene; second, the j3-subunits of Hb are more stable than a-subunits and can 
reversibly form 134 tetramers (HbH) (Steensma et al., 2005). The excess a-chains in 13-
thalassemias leads to toxic aggregates that accumulate in cell membranes as well as in red 
cell inclusion precipitates called Heinz bodies (Bank, 2(07). 
Importance of heme homeostasis 
Heme is present in almost all living organisms, except for a few anaerobes and a 
few unicellular organisms auxotrophic for heme (and related porphyrins) (Ponka, 1997). 
Heme biosynthesis in mammalian cells is a finely tuned process, which consists of a 
well-conserved eight-enzyme pathway, located in the cytoplasm and mitochondria, with 
final formation of heme occurring in the inner-membrane of mitochondria. The heme 
must then be transported through the mitochondrial membranes to help form functional 
cytosolic heme-proteins including Mb and Hb (Harnza, 2(06). The levels of heme are 
tightly regulated at several control points in the anabolic and catabolic pathways (Bunn 
and Forget, 1986; Harnza, 2006; Jeney et al., 2002; Ponka, 1999; Raju and Maines, 1996; 
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Wagener et al., 2(01). In tum, these levels regulate gene transcription and translation of 
Hb chains (Chen, 2007; Han et al., 2001; Taketani, 2005). 
Human plasma contains many heme-binding proteins (i.e., albumin, hemopexin, 
and lipoproteins) that deliver heme to the liver (Piccard et al., 2007; Stojiljkovic and 
Perkins-Balding, 2(02). Heme released from heme-proteins can readily generate oxygen 
radicals and catalyze the oxidation of lipids, proteins, and DNA (Graca-Souza et al., 
2(02). Heme released from Hb after episodes of intravascular hemolysis has been 
suggested to contribute to acute renal failure (Graca-Souza et al., 2(02). Heme has also 
been considered a causative agent in organ failure after ischemia-reperfusion, in part 
because heme-oxygenase (enzyme which breaks down heme) induction in heart and 
kidney tissue is slow, allowing an accumulation of heme in cell membranes and 
lipoproteins which has been shown to produce large amounts of radicals and reactive 
oxygen species (Graca-Souza et al., 2002; Jeney et al., 2002; Raju and Maines, 1996; 
Wagener et al., 2(01). 
Heme is a very good source of iron for humans and bacteria. Some micro-
organisms are unable to synthesize heme and require large amounts of heme to grow in 
vitro. The availability of heme plays a role in virulence of certain bacteria (Stojiljkovic 
and Perkins-Balding, 2002) in part because most pathogens prefer heme as an iron source 
(Rouault, 2004). Consequently, the accumulation of free heme in cells and in blood is 
tightly regulated and suppressed to avoid pathogenesis (Rouault, 2(04). 
Human apoHhA dimers 
Removal of heme by extraction into acid-acetone mixtures and then refolding by 
slow dialysis into neutral pH buffer (Ascoli et al., 1981) leads to formation of al~l apo-
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dimers (Fanelli et al., 1958; Rossi-Fanelli et al., 1964; Winterhalter and Huehns, 1964; 
Yip et al., 1972), which have 48% helicity of native holoHbA (Hrkal and Vodrazka, 
1967). These apoHb dimers are still capable of reacting rapidly with free heme to 
reconstitute intact and functional holo-tetramers (Winterhalter and Colosimo, 1971; 
Winterhalter and Huehns, 1964). When heme is removed from isolated a and 13 subunits, 
almost all secondary structure is lost; the apoproteins precipitate at temperatures greater 
than 15 DC; and reconstitution with added heme does not occur in the absence of partner 
subunits (Waks et al., 1973). 
Heme binding to apoHb 
The binding of heme to folded apoHb has been studied for .... 50 years (Adams, 
1976; Antonini and Brunori, 1971; Antonini and Gibson, 1960; Gibson and Antonini, 
1960) and most studies have shown that heme binds very tightly (K.t .... 10-11 to 10-14 M) to 
both apoMb and the a and 13 subunits of apoHb. The a subunit has a higher affinity for 
hemin than the 13 subunit (Cassoly and Banerjee, 1971; Winterhalter et al., 1968) despite 
similar association rate constants for heme binding to the two different apoglobin 
subunits (Rose and Olson, 1983). Thus, there is a redistribution of heme from the 13 to the 
a subunit over time in experiments involving one heme per apoHb dimer (Winterhalter et 
al., 1968; Winterhalter and Deranleau, 1967). This difference in affinity was confirmed in 
hemin dissociation experiments which showed that the rate of hemin dissociation from 
the 13 subunits is .... 3 fold larger than from the a subunits in metHb tetramers and dimers 
(Hargrove et al., 1997). In addition, hemin affinity differs between the monomers, dimers 
and tetramer (Hargrove et al., 1997) and losses of heme from the Hb subunits causes 
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much larger loss of secondary structure than what is observed during apoMb formation 
(Leutzinger and Beychok, 1981). 
How is Hb synthesized? 
The a and ~ subunits chains of Hb are formed separately on the ribosome 
whereas heme synthesis mostly occurs within mitochondria. It is still uncertain how the 
Hb chains fold (co-translationally or post-translationally) and when heme specifically 
interacts with the nascent chains. Most workers believe that apo-globins first fold and 
then bind heme; however, heme could interact prior to a fully formed apo-globin (Komar 
et aI., 1993). Mammalian Hb chains are translated in about one minute (Dintzis, 1961; 
Goustin and Wilt, 1982), whereas folding of globin chains in vitro is accomplished in a 
few seconds. Heme binding to the folded state also occurs very rapidly (Hargrove et aI., 
1996a; Rose and Olson, 1983). In vitro studies have demonstrated that without heme 
present, globin synthesis does not proceed, and those apo-chains that are made are 
unstable and rapidly aggregate (Chen, 2(07). 
Until recently, hemoglobins and myoglobins were believed to fold without the 
help of molecular chaperones. The discovery of the a-hemoglobin stabilizing protein, 
AHSP, by Weiss and coworkers (Gell et aI., 2002; Kihm et aI., 2(02) has refocused 
interest on the assembly of Hb. Even though free a-chains are cytotoxic by producing 
precipitates and reactive oxygen species (Feng et aI., 2004; Feng et aI., 2005; Scott et aI., 
1993), a small excess of a-chains are normally formed in pre-erythroid cells (two alleles 
for a versus one allele for ~ chains) forming free pools of a-chains (Baglioni, 1968; 
Baglioni and Campana, 1967; Shaeffer, 1967; Tavill et aI., 1967). AHSP is thought to be 
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an erythroid chaperone that stabilizes free a-chains in the absence of f3-chains (Bank, 
2007; Kihm et al., 2002; Weiss et al., 2005; Yu et al., 2(07). In addition, heme delivery 
to nascent chains has been suggested to be the limiting factor in formation of functional 
Hb (Levere and Granick, 1965). Thus, AHSP may participate in helping proper assembly 
of Hb by assuring that a chains are not degraded prior to heme incorporation (Mollan et 
al.,201O). 
Hemoglobin assembly during erythropoiesis is extremely complex and the 
question of when heme binds to globins chains still remains unresolved despite many 
efforts in the hematological, biochemical, and biophysical fields. Because apoHb dimers 
form when heme is removed from tetramers, even at high concentrations, we assume that 
the a and f3 subunits first fold up into apo-dimers which then bind hemin. These ideas are 
explored in Chapter 7. 
1.6. General relevance and heme protein biology 
Biqphysical 
More than 30% of proteins in cells bind a cofactor in order to function properly 
(Gray, 2(03). Most, if not all, cofactor-binding proteins are significantly more stable in 
their holo form compared to their apo-form, as reviewed in (Wilson et al., 2004). This 
situation is clearly the case for Mb (Hargrove and Olson, 1996), azurin (Leckner et al., 
1997), and flavodoxin (Apiyo and Wittung-Stafshede, 2(02) (Fig. 1.8). 
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Figure 1.8. Crystal structures of three model cofactor-proteins. Ribbon representation of D. vulgaris 
flavodoxin (PDB entry: 2fx2) with flavin mononucleotide (FMN, purple sticks), P. aeroginosa azurin 
(PDB entry: lazu) with copper ion (blue sphere), and sw Mb (PDB entry: Ijp6) with heme (red sticks with 
the iron as a sphere). Images created using Pymol. 
The folding and assembly of cofactor-binding proteins is in most cases poorly 
understood. Some proteins have been suggested to retain their cofactor upon unfolding, 
although the binding is normally much weaker (e.g., cytochrome b562 (Robinson et al., 
1997) and azurin (Marks et al., 2004». Heme has been suggested to bind weakly to the 
unfolded Mb polypeptide after denaturation (Hargrove and Olson, 1996). Heme might 
also be able to bind more specifically to folding intermediates and modulate the kinetic 
and equilibrium unfolding/refolding pathways (Fig. 1.9). 
Free cofactor 
+ 
+ 
Cofactor binding 
Unfolded 
polypeptide 
B 
A 
B 
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Figure 1.9. Three possible assembly mechanisms involved in Mb assembly, which includes polypeptide 
folding and cofactor binding. The mechanisms are represented where (A) the cofactor binds first, (B) the 
cofactor binds after folding, and (C) the cofactor binds simultaneously with folding. Ribbon representation 
of the crystal structure of WT aquomet sw Mb (PDB entry: Ijp6) using PymoI. The NMR structures for the 
apoglobin native (Eliezer and Wright, 1996; Eliezer et aI. , 1998; Lecomte et al., 1999) and intermediates 
(Eliezer et aI., 2000; Eliezer et aI., 1998; Griko et aI. , 1988; Hughson and Baldwin, 1989; Hughson et aI. , 
1991; Hughson et aI., 1990; Jennings and Wright, 1993; Nishimura et aI., 2003) states are represented in 
ribbon and thin loops for the folded and unfolded regions, respectively. Figure adapted from Wilson et al. 
(2004) 
Understanding of the role of heme in the unfolding of Mb and Hb in vitro will 
establish new insights in the folding pathways of homologous heme-proteins (e.g., 
flavoHbs, neuroglobins, and cytoglobin). In addition, our new work was designed to test 
quantatively whether heme can bind only after the apoglobin chains are completely 
folded or if it can bind intermediate states (Bank, 2007; Hargrove et aI., 1996a; Yu et aI., 
2007). 
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Clinical/pathophysiological conditions 
All the factors involved in the formation of Hb are relevant in understanding 
erythropoiesis. Unraveling how heme modulates the folding of Mb, and Hb, will lead to a 
better understanding of the synthesis and degradation of Hb, and pathologies associated 
with unstable mutants. These results may provide insights to control anemias caused by 
unstable hemoglobins and the equally serious thalassemias, caused by unbalanced 
expression of the a and f3 chains. 
Finally, understanding the factors that contribute to Mb denaturation may lead to 
the design of new treatments to reduce toxic accumulation of apoMb and hemichrome 
intermediates in renal tubules of patients suffering from rhabdomyolysis (in combination 
with various continuous hemofiltration methods) (Bellomo et al., 1991; Naka et al., 
2(05). Myocyte apoptosis induced by oxidation and hemin loss from Mb has been shown 
to playa role in ischemia-reperfusion injury (Scarabelli and Gottlieb, 2(04), and thus 
understanding of how heme modulates the in vitro formation of Mb may allow us to 
inhibit the rate and extent of Mb unfolding, which could help treat injuries due to muscle 
trauma and ischemiaireperfusion. 
Biotechnological application 
One of the medical dilemmas of today is the widespread shortage of blood 
available for blood transfusions required for immediate treatments of unremitting military 
incidents and civilian disasters (Olson, 2(05). Therefore, the creation of a non-pathogenic 
blood substitute that is commercially feasible is extremely important. One approach is to 
engineer a blood substitute using recombinant Hb over-expressed in E. coli (Dou et al., 
2002; Graves et al., 2(08). However, low expression yields and prohibitive costs have 
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precluded development of Hb products even though the major side effects such as high 
blood pressure, vascular lesions, and gastrointestinal dysmotility have been inhibited by 
re-engineering the active site of the 2 a and 13 subunits (Dou et al., 2002; Olson, 2(05). 
Mb has been used as a model system for designing heme protein based blood 
substitutes for several years. One of the factors that limits the expression yield of holoMb 
and holoHb in E. coli appears to be correlated with the stability of the apoglobins (Dou et 
al., 2002; Graves et al., 2008; Smith, 2(03). In addition, production of intact holoMb and 
holoHb in E. coli is limited by the rate of heme uptake (Olson, 2(05). The understanding 
of how the stability of Mb in the folding pathway is modulated by the presence of heme 
and determining when heme binds will allow the design of recombinant proteins that are 
more stable and express at higher levels. This information could be vital for optimization 
of recombinant Hb production and reduction in costs. Exogenous heme may need to be 
added or heme transporters co-expressed at the time of induction to avoid possible 
aggregation products formed from apoHb subunits. 
1.7. Thesis goals and organization 
The overall goal of this thesis was to investigate the role of heme in the unfolding 
and assembly of globins. The work and interpretations are divided into six chapters 
(Chapters 3-8), followed by references, and an appendix that includes the mathematical 
derivations for the equations in Chapters 3-7 and computer code (Chapter 5). Materials 
and Methods are given in Chapter 2. 
Chapter 3 presents the theoretical background for resolving the effect of heme 
remaining non-specifically attached to the unfolded polypeptide, and self-associating to 
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fonn free hemin dimers. Remarkably, no one had derived expressions for quantifying 
how heme binding modulates the folding of hemoproteins. Three possible unfolding 
mechanisms were postulated and used to simulate the dependence of protein 
concentration on the apparent stability of a monomeric globin that unfolds by a simple 
two-state mechanism. 
In Chapter 4, a detailed theory for the unfolding of holoMb is presented and takes 
into account the intennediate observed in the unfolding of the apoglobin. Sw Mb was 
chosen as the classic monomeric globin to investigate whether heme binds only to the 
fully folded N apo-state or also binds to the apoMb folding intennediate. Sw Mb is 
homologous to human Mb with 82% sequence identity; however its increased stability in 
both the apo and holo fonns allows for mutations to be made without complete loss of 
structure and expression in E. coli. I used a mechanistic approach in which the 
equilibrium-unfolding of the holoprotein can be interpreted in a six-state scheme, based 
on the three-unfolding states N, I, and U of apoMb. The use of mutagenesis to markedly 
change the stability of the N apo state or its affinity for hemin was crucial for verifying 
our mechanism and interpretations. 
In Chapter 5, the effects of hemin dimerization and protein concentration, on the 
unfolding of holoMb were investigated using the six-state scheme from Chapter 4 and a 
hemin dimerization step, which, as shown in Chapter 3, can affect the observed unfolding 
curves but markedly complicates the analysis. Unfolding curves of WT and H97D 
holoMb were measured at three different protein concentrations and then fit to the six-
state scheme with hemin dimerization. 
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In Chapter 6, Cerebratulus lacteus hemoglobin was used as a simple monomeric 
model to verify our approaches and analyses. CerHb does not appear to populate an 
intermediate in the apoform and thus we could use a four-state scheme to analyze the 
equilibrium unfolding of holoCerHb. 
In Chapter 7, my goals were two fold: first, to build equilibrium-unfolding models 
to explain how the apoHb dimer assembles, and second, to prove that hemichrome 
formation also occurs during the unfolding of aquomet HbA. Even though the results in 
this chapter are limited, they provide evidence that a hemichrome is on pathway for the 
assembly of HbA, and such hemichromes are directly relevant to the biology of the 
eythrocyte and formation of Heinz bodies. My thesis conclusions are presented in 
Chapter 8 and include correlations between chemical denaturant and thermal stabilities 
for apo and hologlobin variants, and provide insights and directions for future 
experimental projects. 
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Chapter 2 
Materials and methods 
2.1. Protein preparation 
Sperm whale Mb 
Wild-type sperm whale myoglobin was prepared according to Springer and Sligar 
(1987) as modified by Carver et al. (Carver et al., 1992). The H64F and V68T mutant 
genes were constructed using the cassette mutagenesis system developed by Barry A. 
Springer and Karen Egeberg at the University of Illinois (Springer et al., 1989). The 
T67P and H97D mutants were reconstructed at Rice University for this work using 
oligonuc1eotide--directed mutagenesis with a pET29 vector containing the gene for WT 
Mb to increase yields. All variants were expressed and purified at Rice University 
following the procedures used for WT Mb, except for the T67P and H97D mutants, 
which were expressed in E. coli BL21-DE3 (Stratagene) and grown at 30 "C for 16-20 hrs 
post lag phase in Luria-Bertani media with 50 J.l.g/mL kanamycin (Sigma). If needed, the 
protein was purified further using a Superdex-200 gel filtration column (Amersham 
Biosciences) attached to an FPLC (Amersham Bio AKTA), and the purity was ~ 95% as 
assessed by SDS-PAGE gels and Soretl280 absorbance ratios. The holoMb 
concentrations were determined spectroscopically using E409= 157 mM·\ cm·\ for the 
aquomet forms of WT, T67P, V68T, and H97D Mb (Antonini and Brunori, 1971) and 
with E393= 93 mM-I cm·1 for the ferric pentacoordinate H64F variant (based upon the CO-
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bound form at 424 run using £424= 187 mM-' cm-' for all the MbCO samples (Antonini and 
Brunori,1971). 
Cerebratulus lacteus Hb 
Recombinant wild-type CerHb was expressed and purified at Rice University, 
using a synthetic gene and codon usage optimized for expression in E. coli (Pesce et al., 
2004; Pesce et al., 2(02). Reduced protein was oxidized with potassium ferricyanide, and 
isolated with a G-25 gel-filtration column with 10 mM phoshate pH 7. The protein 
concentration was determined using £406= 179 mM-' cm-' . 
Human adult HbA 
Native Human Hb was obtained from outdated blood units from the Gulf Coast 
Regional Blood Bank in Houston and was prepared according to (Reisberg, 1980). 
Briefly, the protein was isolated by centrifugation and lysis of the erythrocytes, purified 
by gel chromatography, and stored in the CO form at -80°C. The aquomet form used in 
the experiments was obtained by replacing CO with O2 under an intense light, and 
addition of a slight excess of potassium ferricyanide to oxidize the heme iron. Excess 
oxidizing agent was immediately removed by G25 gel chromatography. The oxidized 
protein was used immediately to avoid heme loss and degradation. The protein 
concentration was determined spectroscopically using £406= 179 mM-' cm-' based on the 
CO form (Antonini and Brunori, 1971). 
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Preparation ofapoproteins 
ApoMb and apoCerHb were prepared using a methyl-ethyl ketone extraction 
method at low pH (Ascoli et al., 1981; Hargrove et al., 1994b). I was able to optimize the 
preparation of apoMb by ensuring that the protein was dilute (> 100 JAM), and only 
contained trace amounts of salt and buffer prior to the addition of acid. We were able to 
obtain yields of >90% apoprotein from wild-type Mb. The resultant apoprotein was then 
filtered to remove any precipitated protein and used immediately. The concentrations of 
apoMb and apoCerHb variants were determined spectroscopically using £280= 15.2 (Light, 
1987) and 12.5 mM-! cm-! (estimation from the aromatic residue content), respectively. 
ApoHbA was prepared using the acid-acetone method (Ascoli et al., 1981) and protein 
concentration was determined using £280= 12.7 mM-! cm-! on a subunit basis. Residual 
heme was very minimal in all apoproteins with less than 0.5% for apoMb and apoCerHb, 
and less than 2% for apoHbA as determined by the Soret to 280 nm absorbance ratios. 
2.2. Theoretical and experimental approaches to protein folding 
In most cases, proteins fold spontaneously. From an energetic perspective, this 
means that the folding process is thermodynamically favorable and the folded 
conformation is in a state of lower free energy compared to the unfolded state (or 
ensemble). The difference, expressed as the Gibbs free energy change AG, is a measure 
of a protein's stability, and is governed by the balance between enthalpic (MI) and 
entropic (L1S) contributions depending on the temperature (n, as represented by: 
AG-Ml-TAS (2.1) 
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Upon folding, proteins fonn hydrogen bonds, salt bridges, and hydrophobic 
associations overcome the entropic cost of restricting the number of random structures. 
The folding free energy of most proteins is only -- 5-10 kcal/mol, which is equivalent to a 
few hydrogen bonds, tipping the balance in favor of the folded state. The folding process 
can be mathematically simulated using a funnel-like energetic landscape, where the 
protein is allowed to fold to the state of lowest energy through a large number of 
pathways and intennediates. In vitro, conversion of folded to unfolded states of proteins 
can be induced upon addition of chemical denaturants or heat, and the process can be 
monitored experimentally by several methods. As proteins increase in size (and length), 
the folding process becomes more complex, often involving intennediates and requiring 
chaperones, which renders quantitative analyses more difficult. 
2.3. Spectroscopic characterization of protein folding 
Proteins possess unique primary, secondary, tertiary, and quaternary structures, 
which can be characterized in solution by various spectroscopic methods. Spectroscopy 
relies on how magnetic fields and electro-magnetic radiation can be altered in the 
presence of proteins. The main spectroscopic methods used for biophysical 
characterizations of proteins are: Electron Paramagnetic Resonance, X-ray 
crystallography, Infra-Red, Raman, UV -Vis absorption, Fluorescence, Circular 
Dichroism (CD), and Nuclear Magnetic Resonance. In this work, UV-Vis absorption, far-
UV CD, and fluorescence emission methods were used to monitor the unfolding of apo-
and holo-globins. 
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Fluorescence 
Fluorescence is the rapid emission of light by a fluorophore that has been excited 
by absorbed light. Emission occurs when an orbital electron relaxes from the excited state 
S) to its ground state So by emitting a photon of longer wavelength than the excitation 
light. The bathochromic shift between excitation and emission is caused by the loss of 
energy through non-radiative relaxations, releasing heat to the solvent, upon excitation. 
Fluorescence can be used to study protein folding as a non-damaging technique to 
monitor the change of environment of either intrinsic (e.g., Trp, Tyr, or Phe) or extrinsic 
(fluorescent labels/dyes) fluorophores of a protein during folding/unfolding. For example, 
the emission from a Trp residue is very sensitive to its environment and can therefore be 
used as a tool to investigate tertiary structure empirically. 
Circular dichroism 
Circular dichroism relies on the differential absorption of left and right circularly 
polarized light upon interaction with a protein. The spectrum in the far-UV is dominated 
by the amide chromophore, which is diagnostic of the backbone conformation (secondary 
structure), whereas the spectrum in the near-UV provides information on the aromatic 
and disulfide transitions, which are dependent on the side-chain environment (tertiary 
structure). In the far-UV range (190-250 nm), the spectrum can reveal important 
components of a protein's secondary structure: a-helix, ~-sheet, ~-turn, and random coil. 
The characteristic 208-222 nm and 215 nm minima for proteins with high a-helical and 
~-sheet content, respectively, are due mainly to the n-3t* transition and static-field 
mixing between the n-3t* and 1to-3t* transitions (Berova et al., 2000). 
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UV-visible absorbance 
Absorbance in the UV -visible region is an important quantitative tool for 
characterization of the electronic transitions of transition ion metals and highly 
conjugated organic compounds. Absorbance in the visible region gives rise to the 
observed colors of these cofactors, making it a very useful assay for rapid identification 
of these compounds. In the case of globins, changes in the axial ligand and oxidation 
state cause large changes in the cofactor's UV-visible absorption spectrum, which can be 
used to monitor various processes including unfolding and heme loss. 
Equilibrium-unfolding 
Measurements of equilibrium-unfolding are used to investigate the stability of 
proteins. Unfolding is triggered by addition of denaturant and monitored by following 
changes in secondary and tertiary structures using CD and/or Trp or Tyr fluorescence 
measurements, respectively. Sets of samples are prepared using various amounts of 
denaturant along with appropriate amounts of water, buffer, and protein. The presence of 
denaturant (e.g., acid, GuHC1, GuSCN, or urea) is believed to destabilize the native 
folded state of a protein with respect to its unfolded state by strong electrostatic 
interactions with the highly polar amide backbone. To ensure equilibrium, a minimum 
incubation time must be determined after which the interconversion rates between folded 
and unfolded states are equal. The ability of a protein to fold back to its original state 
once unfolded is termed reversibility, and is important for accurately determining the 
stability and folding constants of a protein using equilibrium analyses. Information 
concerning the composition of each sample (i.e., folded, intermediate, and unfolded 
states) can then be retrieved to determine thermodynamic stability parameters. In simple 
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systems, proteins unfold by a two-state, highly cooperative process that is well defined 
and resembles a phase transition. 
2A. Protein experiments 
Chemical eQuilibrium-untoldine 
The samples were prepared using 8 M stock guanidine hydrochloride (GuHCl) of 
very high purity (Sigma), appropriate amounts of potassium phosphate buffer (Fisher 
Scientific) to bring the concentration to 10 or 100 mM at pH 7, purified milliQ water and 
concentrated protein. The mixtures were left to equilibrate for two hours at the desired 
temperature. A Jasco 810 was used for CD experiments, a Varian Cary Eclipse for 
fluorescence emission, and a Varian Cary 50 for UVNisible absorbance measurements. 
Each sample chamber was equipped with a Peltier temperature regulator. A reference 
hemichrome spectrum was generated by adding high concentrations of imidazole to the 
ferric myoglobins using a pH-adjusted 1 M stock solution from the powder form (Sigma). 
To examine the reversibility of hemichrome formation, metMb samples containing 
hemichrome intermediates were rapidly reduced anaerobically by addition of sodium 
dithionite (Fluka). 
Thermal unfolding 
Thermal melts monitored by CD at 222 nm (secondary structure) were performed 
on a Jasco 810 spectropolarimeter equipped with a Peltier unit and unfolding was 
performed in a 1 mm quartz cuvette with a scan rate of 1 DC/min for both the apo and 
holo proteins. 
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Hemin dissociation assays 
The measurements of the rates of hemin dissociation were carried out using 4 JA.M 
of the desired metglobin with 40 JA.M apo H64YN68F sw Mb (termed hemin loss 
reagent) as described in (Hargrove et al., 1994b). The heme loss reagent in the ferric form 
has a different absorbance spectrum in the visible range than most ferric globins, which 
allows for the transfer of heme between the desired metglobin and the hemin loss reagent 
in the apo form to be followed spectrally. The globin of interest must be in the ferric 
aquomet form, as heme loss in the reduced state is too slow to measure (Hargrove et al., 
1996b, k.H> several days). Globins at equilibrium continuously lose and rebind heme, but 
in the presence of the apo-reagent in excess (to-fold in our experiments), most of the lost 
heme is immediately scavenged by the apo-reagent, generating the "green" holoMb 
reagent. 
Chapter 3 
General mechanisms for the unfolding of 
monomeric globins 
This chapter is adapted from: 
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Culbertson, D.S., and Olson, 1.S. (2010). Folding and Assembly of Myoglobins and 
Hemoglobins. In Protein Folding and Metal Ions: Mechanisms, Biology, and 
Disease, P. Wittung-Stafshede, and CM. Gomes, eds. (Taylor and Francis, Inc.) 
pp.97-122. 
3.1. Introduction 
Monomeric holo-globins and related type b heme monomers (e.g., cytochrome 
b562) appear to unfold at equilibrium by simple two-state mechanisms at much lower pH 
values or higher denaturant concentrations than the corresponding apoproteins. In all 
cases, the holoprotein is stabilized markedly by the presence of heme (Hargrove and 
Olson, 1996; Robinson et al., 1997). There have been many speculations on the fate of 
heme during the unfolding of globins. The observed lack of protein concentration 
dependence during chemical (Hargrove and Olson, 1996) and thennal (Robinson et al., 
1998) denaturation of holo-Mb and cytochrome b562 , respectively, suggests that heme 
may remain bound even after unfolding of these hemoproteins. To examine the possible 
causes for the lack of protein concentration dependence, I evaluated three possible 
equilibrium-unfolding mechanisms for a monomeric holoHb (NH, where N represents the 
native fold with heme, H, bound to it). The models include: (1) no hemin (H) binding to 
the unfolded apoHb state (U); (2) binding of hemin to the U state (UH); (3) and self-
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association of hemin to form dimers (H2) . To simplify the analysis and focus on the fate 
of the heme, the apo-form of the monomeric globin was assumed not to possess an 
intermediate in the folding pathway of the apoglobin. Mathematical expressions were 
derived to simulate the dependence of the unfolding curves on protein concentration for a 
simple monomeric globin. These simple mechanisms differ significantly with respect to 
the dependence of the unfolding curves on the absolute initial holoprotein concentration, 
and provide insights that were further tested in Chapters 4 and 5. 
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Figure 3.1. Simulated effect of protein concentration on the unfolding curves of monomeric globins for 
three different mechanisms with different fates of dissociated hemin. The panels on the left describe the 
reaction schemes, and the panels on the right show simulated unfolding curves at Po = 1 !J.M (dotted line) , 
20 !J.M (dashed line) and 400 !J.M (solid line). A. Simple mechanism where hemin remains free and 
monomeric after dissociation and protein unfolding (Appendix A.1.). The following constants were used: 
KNUO = 1.0 xlO-\ mNU = 3.1 kcal mol-I M-I , K NHO = 10-12 M, mNH = 3.6 kcal mol-l M-l and T= 20 °e. B. 
Mechanism where dissociated hemin can bind to the unfolded state U (Appendix A.2) . The values from A 
were used and additionally: K UHO = 1.0 xlO-8 M and mUH = 1.7 kcal mor l M-I. C. Mechanism where 
dissociated hemin self-associates to form a dimer (Appendix A.3). The values from A were used and 
additionally: KH/= 4.5 X 106 M-l (de Villiers et aI., 2007), mH2= 1.0 kcal mol-I M-I (unpublished data) . 
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3.2. Model with monodisperse free hemin 
The simplest mechanism for the unfolding of a monomeric holo-globin assumes 
that the released hemin remains monodisperse and that, after hemin dissociation from the 
holoHb, unfolding of the resultant native apoHb (N) is a simple two-state process, N-to-U 
(Fig. 3.1A). In this case, the equilibrium constants are defined as: 
K = [U] =Ko exJ mNu[GUHC1]) 
NU [N] NU ~ RT (3.1) 
K = [NUH] = K O exJ mNH[GUHC1]) 
NH [NH] NH ~ RT (3.2) 
The concentration of denaturant [GuHCI] exponentially increases the KNH and K NU 
constants as defined by mNU and mNH, respectively. The total protein concentration at any 
titration point is given by: 
P. -[NH]+[N]+[U] = [NH] 1+-.M!.+ NH NU ( KKK ) 
° [H] [H] (3.3) 
KNH is the equilibrium constant for the dissociation of hemin from native state, K NU is the 
unfolding constant for the N to U transition, and NH, N, U, and H represent monomeric 
holoHb, the folded native apo-state, the unfolded apo-state, and free hemin, respectively. 
Derivations of the fractions of each protein species, NH, N, U, and free H are 
given in the Appendix A.I. The expressions are complex because hemin binding is a 
bimolecular process that is favored at high initial holoHb concentrations. As a result, the 
free concentration of hemin, H, is a function of denaturant and total protein concentration 
Po, and is defined by the following expression: 
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The fraction of native holo-globin is defined by: 
(3.5) 
where [H] is given by Equation 3.4. The fractions of Nand U can be retrieved in a similar 
manner. As shown in Fig. 3.1A, this simple mechanism predicts that the holoHb 
unfolding curves should be strongly dependent on the total protein concentration. A 
marked right-shift of the GuHCI-induced unfolding curves will occur with increasing 
protein concentration if hemin remains mono-disperse after dissociation from the globin. 
3.3. Model with hemin binding to the unfolded state 
Expansion of the previous mechanism allows hemin to stay bound after unfolding 
or re-association with the unfolded state to produce a fourth UH state (Fig. 3.1B). 
Binding of hemin to the unfolded U state of Mb was proposed by Hargrove and Olson 
(1996) because they observed little protein concentration dependence for GuHCI-induced 
unfolding of holoMb, and this phenomenon was also observed for the thermal unfolding 
of cytochrome b562 (Robinson et al., 1998). Hemin is relatively insoluble, binds non-
specifically to a variety of proteins, and is found in globin precipitates in red cells (i.e., 
Heinz bodies) under pathological conditions (Bunn and Forget, 1986). 
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Hemin binding to unfolded apoHb adds another protein species and equilibrium 
equation to the original mechanism, and this binding and the total protein concentration 
are defined by: 
K ==[U][H)=Ko exJmuH[GUHC1)) (3.6) 
UH [UB] UH ~ RT 
Po = [NH)+[N)+[U) + [UH) = lNH)(l + KNH + KNHKNU + KNHKNU ) (3.7) 
[H) [H) KUH 
The complete derivation for this four state mechanism is given in the Appendix 
A.2, and again a quadratic equation in [H] is generated with an even more complex root: 
(3.8) 
The fraction of folded holo-NH is defined as before but contains the additional [UH] term 
in the denominator: 
(3.9) 
Allowing heme binding to the unfolded state decreases the stabilizing effect of 
increasing protein concentration because as Po increases, the fractions of NH and UH 
both increase. As a result, the unfolding curves show much less dependence on globin 
concentration (Fig. 3.1B). At very high protein concentrations, where Po -100 times the 
Kd for hemin binding to the U state, there is little or no free hemin during unfolding and 
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the unfolding process becomes effectively unimolecular, NH to UH. Under these 
conditions, there is very little protein concentration dependence and the process appears 
to be simple two-state process (see dashed and solid lines in Fig. 3.IB). 
3A. Model with hemin dimerization 
Another potential complication is that free hemin can forms dimers and higher 
order aggregates with itself at neutral pH, even at micromolar concentrations (Adams, 
1977; Brown et al., 1970; de Villiers et al., 2007). The third mechanism in Fig. 3.1 allows 
self-association of free hemin to form dimers after dissociation from the holo-protein 
(Fig. 3.1C). A complete derivation is given in the Appendix A.3. In this case, the 
additional step is described by a hemin dimerization constant, KH , which is defined by: 
2 
K = _lH_2_1 ... KO exJ_m...:..:H",-z l_G_U_R_C_1l) 
Hz lH]2 Hz \ RT (3.10) 
In this mechanism, the total free hemin also includes dimers (i.e., Hrree = [H] + 2[H2] = 
[N] + [UD. As a result of this bimolecular hemin association step, the final equation for 
[H] is a cubic equation, and Cardano's method was used to find the appropriate root of 
the equation a[H]3+b[H]2+c[H]+d, which is: 
b [H]=--
3a 
__ 1( 2b2 - 9abe + 27a2d + ~(2b2 - 9abe + 27a2df - 4( b2 - 3ae f 1 
3a 2 
__ 1 [ 2b2-9abe+27a2d-~(2b2-9abe+27a2df -4(b2-3acf 1 
3a 2 
using the following coefficients for the cubic equations: 
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(3.11) 
(3.12) 
This value of [H] can be used to compute the fraction of native holo-NH as 
defined in the original three-state mechanism, Equation 3.5. 
(3.13) 
In general, the computed unfolding curves for this mechanism show less 
dependence on protein concentration compared to the mechanism where dissociated 
hemin remains free and monomeric in solution. The favorable effect of increasing the 
initial amount of holoHb on resistance to hemin loss is compensated by the increased 
tendency of free hemin to aggregate at higher concentrations. However, the exact 
dependence and shapes of the curves will be strongly dependent on how the denaturant or 
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condition affects the hemin dimerization reaction (i.e., positive versus negative mH2 
values). Thus, any thorough analysis requires examining independently the dependence 
of KH2 on pH, temperature, or denaturant. 
3.5. Conclusions 
The key conclusion from the theoretical curves shown in Fig. 3.1 is that 
hologlobin unfolding ultimately needs to be measured and analyzed carefully as function 
of total protein concentration. This variation is the best tool for discriminating between 
the three possible mechanisms. The 1 to 400 ~M holo-globin concentrations were chosen 
to cover the normal range used in in vitro studies with Hbs and Mbs. In cases where 
unfolding curves for holoMb were measured as function of Po, the observed dependence 
was small and similar to that shown in panels Band C in Fig. 3.1, indicating that 
dissociated hemin may bind to the unfold state (Hargrove and Olson, 1996), and/or 
dimerize (Asher et al., 2009; de Villiers et al., 2(07), but is almost certainly never free 
and monodisperse in solution. 
The lack of protein concentration dependence on unfolding curves of hologlobins 
therefore strongly suggests that heme either interacts with itself or with the unfolded 
protein. The more complex schemes in Figs. 3.1B-C need to be the starting points for any 
analysis of monomeric hologlobin unfolding, despite the apparent simplicity of the 
individual unfolding curves at a fixed protein concentration. These conclusions were used 
in the following Chapters 4 and 5. 
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Chapter 4 
Six-state analysis for the unfolding of myoglobin 
This chapter is adapted from: 
Culbertson, D.S., and Olson, J.S. (2010). Role of heme in the unfolding and assembly of 
myoglobin. Biochemistry 49, 6052-6063. 
4.1. Introduction 
Sperm whale Mb has been used extensively in structure/function studies as the 
classic monomeric globin. In the apoform, Mb populates a well defined intermediate in 
the folding pathway (See Chapter 1.3); however, the mechanism of holoMb unfolding has 
only been addressed in a few studies, and until our work, most analyses were semi-
empirical and assumed an apparent two-state equilibrium and/or kinetic mechanism 
(Moczygemba et al., 2000; Ramos et al., 1999; Regis et al., 2005; Wittung-Stafshede et 
al., 1998). By using a set of five carefully chosen sperm whale metMb variants (i.e., WT, 
H64F, T67P, V68T and H97D, Fig. 4.1), we have been able to demonstrate and then 
characterize heme binding to the apoMb unfolding intermediate. The mutations were 
selected to stabilize the N apoMb state but weaken hemin affinity (H64F), to selectively 
destabilize the N state without affecting hemin affinity or the stability of the I state 
(T67P), to destabilize the N state but enhance hemin affinity (V68T), and to decrease 
hemin affinity without affecting the stabilities of the N and I apo states (H97D). 
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Figure 4.1. Crystal structure of sw 
aquometMb. Ribbon representation 
with residues of interest indicated 
in sticks: His64 (red), Thr67 
(green), Va168 (purple), His97 
(cyan), His93 (navy blue), Trp7 
and Trp14 (yellow). The other His 
residues are indicated in black 
sticks. The A-H helices are labeled 
in white. Heme is represented in 
brown sticks. Image created using 
PyMol and PDB entry: Ijp6. 
Analysis of GuHCI-induced unfolding of these variants requires a six-state 
mechanism containing native (N), intermediate (I), and unfolded (U) apoMb states and 
their hemin bound counterparts, NH (ferric holoMb), IH, and UH. This six-state 
mechanism applies to all monomeric proteins containing non-covalently bound heme 
with an intermediate regardless of the exact nature of the cofactor binding, provides a 
framework for quantifying the factors that contribute to the overall stability of the 
holoprotein, and allows independent and accurate determination of equilibrium constants 
for hemin binding to native and intermediate apoprotein states. 
4.2. Three-state analysis of apoMb unfolding in GuHCI 
As described in Chapter 1, apoMb populates an intermediate in the equilibrium-
unfolding pathway. The unfolding process of apoMb can be followed by CD (secondary 
structure content) and fluorescence emission (environment of Trp7 and Trp14, see Fig. 
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4.1). We have assumed that the signals from both detections report on the same 
intermediate, and, as described by Ramsay et al. (1995), Scott et al. (2000), and Smith 
(2003), the unfolding data can be fit to a two-step/three-state N-to-I-to-U equilibrium-
unfolding mechanism analogous to the one originally developed by Barrick, Baldwin, 
and colleagues (Barrick and Baldwin, 1993a; Barrick et al., 1994; Griko et al., 1988; 
Nishii et aI., 1995). 
The amount of helical content was analyzed by measuring ellipticity at 222 nm. 
Changes in the environment of the Trp side chains were followed by measuring 
fluorescence emission at 341 nm, which gives rise to a bell-shaped curve with an increase 
in fluorescence for the intermediate I state and a decrease for the completely unfolded or 
U state (see Fig. 4.2; Hargrove et al., 1994a; Ramsay et al., 1995; Scott et al., 2000). 
This rise and fall in fluorescence intensity allows for a better definition of the three-state 
unfolding parameters. The origin of hyperfluorescence from the intermediate state still 
remains unclear. Fluorescence of WT apoMb has been suggested to reflect emission from 
Trp7 centered at 333 nm, which is quenched by Lys79 and/or Met131 in the folded state 
but not in the intermediate, and emission centered at 321 nm from Trp14, which is buried 
in the apolar region between the A, G, and H helices in both the N and I states and only 
quenched after unfolding (Hargrove et aI., 1994a; Irace et al., 1981; Kirby and Steiner, 
1970; Tcherkasskaya et al., 2000a; Tcherkasskaya et al., 2000b). Alternatively, the 
hyperfluorescence of the intermediate could be caused by enhanced flexibility of the 
fluorophores in the intermediate state (Ervin et al., 2002). 
The stability of the apoMb variants are defined by the KN10 and KlUo equilibrium 
stability constants for the N-to-I and I-to-U transitions, respectively, and the linear 
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dependences of the corresponding free energies on GuHCl concentrations are defined by 
the mNT and mw values. 
K = [I] = K O exJ mNT[GUHC1]) 
NT [N] NT ~ RT (4.1) 
K =[U]=KO exJmw[GUHCl]) 
w [I] w ~ RT (4.2) 
The observed signal at a given [GuHCI] is the weighted sum of the observable 
signals, SN' SI' and Su, for each state (Barrick and Baldwin, 1993b; Hargrove et al., 
1994a; Scott et al., 2000; Smith, 2(03), which is expressed as: 
S S Ko ~mNT[GUHCl]) C' KO KO ~(mNT +mw )GUHCIJ) N+ T NT ex + 03u NT w ex RT RT 
S=---------------------------,~----~----_.~ 
1 Ko ~mNT[GUHCl]) KO KO ~(mNT +mw)GuHCIJ) + NT ex + NT w ex RT RT 
(4.3) 
The mNT and mw values for the N-to-I and I-to-U transitions in apoMb were fixed 
to 2.35 and 1.36 kcal mol-' M-', respectively (Scott et al., 2000; Smith, 2(03), assuming 
that the single point mutations do not significantly affect the change in hydrophobic 
exposure between the N, I, and U states. Only the unfolding parameters, KNTO and Kwo, 
were allowed to modulate the N-to-I, and I-to-U transitions of the apo-variants. 
Definition af the signal parameters for analysis of apoMb unfolding curves using the 
three-state mechanism 
The CD and fluorescence curves for unfolding of the five apoMb variants were fit 
to the three-state N-to-l-to-U mechanism using Equation 4.3 and in Fig. 4.2. The fitted 
signal parameters for the N, I, and U states are listed in Table 4.1 and obtained from the 
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global fits of the CD data at 222 run (CD) and the fluorescence data at 341 run (F). The 
unfolding equilibrium constants are given in Table 4.1. The fluorescence emission of the 
molten globule I state intermediate at this wavelength, SI(F), varies significantly and is 
-1.8 to 3.6-fold higher than that of unfolded state, Su(F) which was normalized to be 1.0 
for all the variants. 
Table 4.1. Respective circular dichroism and fluorescence signals for the three states of the apoMb variants 
ApoMb WT H64F T67P V68T H97D 
variant 
SN(CD)I 1.00 1.22 0.75 1.08 1.02 
SI(CD)I 0.42 0.78 057 0.34 0.41 
SU(CD)I 0.00 0.00 0.00 0.00 0.00 
SN(F) I 1.03 1.09 0.55 1.17 0.92 
SI(F) I 1.97 1.79 2.18 2.17 357 
Su(F)1 1.00 1.00 1.00 1.00 1.00 
IThe CD222nm value of wild-type apoMb N state was normalized to 1.0 (i.e., S~CD) WT =1.0). The SN(F) 
and SI(F) values were allowed to vary, but all the Su(F) values were set to 1 for emission at 341 nm. The 
SI(CD) values were allowed to vary but in some cases are poorly defined when the unfolding transition 
appears concerted; however, all the SI(F) values are well dermed due to the bell-shape the fluorescence 
curves. 
4.3. Equilibrium-unfolding of apoMb variants 
Overlays of both detections for all apo-variants are shown in Fig. 4.2. As 
expected, the unfolding data for the five apoMb variants were readily interpreted in terms 
of a three-state model. In most cases, the CD data reveal an inflection point in the 
unfolding curves indicative of a populated intermediate; however, the CD data alone are 
not sufficient to define accurately the stability parameters for the N-to-I, and I-to-U 
transitions. The fluorescence unfolding curves demonstrate unequivocally the presence of 
an intermediate, which is characterized by hyperfluorescence centered at a wavelength in 
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between the fluorescence peaks for the native N and unfolded U states, as was observed 
previously (Hargrove et al., 1994a; Ramsay et al., 1995; Scott et al., 2(00). 
We successfully obtained fitted KN10 and Kruo stability constants for the N-to-I, and 
I-to-U transitions in the absence of denaturant, and the values are listed along with free 
energy parameters in Table 4.1. The shape of the unfolding curve is directly influenced 
by the population fractions and respective signals for each of the three states (Equation 
4.3). The populations of each state are markedly dependent on the stability constants KN10 
and K/Uo, which vary between the mutants, whereas the m-values for the two transitions 
are relatively invariant and were kept constant. The respective signals for the folded (N) 
and intermediate (I) states of each apoprotein vary due to the structural changes induced 
by the point mutation. These effects are most noticeable for the hyperfluorescence 
intensity of the molten globule intermediate in H64F, which is significantly less intense 
than the one in H97D. This decrease in intermediate fluorescence for H64F could reflect 
a more compact molten globule due to its increased core hydrophobicity and stability. 
The CD unfolding curves also reveal a disparity between the higher helical content of the 
N and 1 states of H64F when compared to lower helical content of for the same T67P 
states (See Table 4.1). 
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Figure 4.2. GuHCI-induced equilibrium-unfolding of apoMb variants. The unfolding curves obtained by 
normalizing the changes in Far-UV CD at 222 run to 1.0 for native WT apoMb and assuming that the U 
states of all five variants have the same CD222nm (left panel) and by normalizing fluorescence emission 
intensities at 341 nm to 1.0 for the final, completely unfolded state of each mutant (right panel). Global fits 
to a three-state mechanism are shown for WT (black), H64F (red), T67P (green), V68T (purple) and H97D 
(cyan). Conditions: 10 J..tM protein, 10 mM potassium phosphate buffer pH 7, 20°C. The three-state 
unfolding mechanism is depicted on the right side, with the structures of N, I, and U states . The structures 
were created using PyMol and the PDB entry: Ijp6 for WT metMb, taking into account the secondary 
structure present in the N state (Cocco and Lecomte, 1990; Eliezer and Wright, 1996; Hughson et aI., 1990) 
and in the I state (Hughson et aI., 1990; Jennings and Wright, 1993). The thick ribbons indicate intact 
helical secondary structure and the thin lines represent unfolded structures. The U state is considered 
completely unfolded. 
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Table 4.2. Stability parameters for the apoMb variants l 
ApoMb variant KNl KlUO IIKNUO 
WT 0.021 0.019 2500 
H64F 0.0061 0.01l 15000 
T67P 0.67 0.029 51 
V68T 0.13 O.ot7 450 
H97D 0.013 0.061 1300 
I The GuHCI-induced unfolding measurements were carried out in 10 mM potassium phosphate pH 7, 20 
°C. The KNlo and KlUO were obtained by fitting simultaneously both CD and Fluorescence signals for the 
unfolding of the apoMb variants to the three-state unfolding mechanism using Equation 4.3 (See Appendix 
A.4). The values of mNI and mlU were set to 2.35 and 1.36 kcal mo.-I M·I, respectively. 
The variants show a wide range of stabilities for the N states, with the H64F 
mutant being the most stable and the T67P variant being the least stable. As expected, 
K/UO is much less affected by these distal pocket mutations than KN10, supporting the view 
that the heme pocket is melted in the molten globule intermediate I state. The H64F 
substitution increases the hydrophobicity of the heme pocket, inhibiting its unfolding and 
decreasing KN/ 3-fold (Table 4.2). The H97D variant displays stabilities for the N and I 
states that are similar to those of WT apoMb because the imidazole side-chain of residue 
97 is solvent exposed. The V68T substitution increases the polarity of the heme pocket 
by inserting an additional polar side chain adjacent to the ligand binding site, and causes 
a marked decrease in the stability of the N state, which is reflected by the 6-fold increase 
in KN10 (Hargrove et al., 1994a). Finally, the T67P variant introduces a "kink" in the E 
helix lowering its stability and that of the entire heme pocket in the N state, resulting in a 
dramatic 3D-fold increase in KN10. 
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4A. Analysis of holoMb equilibrium-unfolding data using a six-state mechanism 
The general scheme for the unfolding of a monomeric heme protein is shown in 
Fig. 4.3, and allows heme, H, to bind to all three apoprotein states: N, I, and U. In this 
equilibrium model, the KNl and KlUo stability constants and m N1 and mlU values for the N-
to-I, and I-to-U transitions of apoMb were determined independently in separate 
experiments with the apo-forms and not allowed to vary (Fig. 4.2). 
KNH NH ..IIII< ___ ====-==ah ..... N + H 
Figure 4.3. Six-state mechanism for the analysis of 
KIH holoMb equilibrium unfolding. The scheme is 
IH -"IIIiii",r===========>a. I + H based upon the three-state unfolding mechanism of 
apoMb and the assumption that heme can bind to 
all three apoMb states. 
KUH UH .... , . ======i=iiii=====h ..... U + H 
Unfolding curves for the holoMb variants were analyzed according to the six-state 
mechanism. The heme dissociation constants from all possible heme-bound states, NH 
(metMb), IH, and UH were allowed to vary in order to define the equilibrium unfolding 
curves for holoMb. The three hemin dissociation constants are defined as: 
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K = [NUH] = K O exJ mNH[GUHC1]) 
NH [NH] NH ~ RT 
(4.4) 
K = [IUH] = K O exJ m/H[ GUHC1]) 
IH [IH] IH ~ RT (4.5) 
K _ [UUH] K O J muH[GUHC1]) 
UH - [UH] UH ex~ RT (4.6) 
The dependences on GuHCI concentrations are represented by mNH, mlH, and mUH. 
To our knowledge, m-values for hemin dissociation from globins have never been 
reported, and our determination of these parameters is discussed later in this chapter. 
The population fractions of each species were computed by ftrst obtaining the free 
concentration of heme [H] by solving for the roots of a complex quadratic equation, 
which leads to the following expression: 
(4.7) 
The fraction of each species was calculated using the free heme concentration [H], the 
two apoMb stability constants, and the three heme equilibrium dissociation constants: 
(4.8) 
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The fraction of free hemin (YH) is given by the sum of the fractions of apoglobin states 
(Y~Yl+YU). Each of the stability and affinity constants depicted in Equations 4.7-8 were 
computed at different [GuHCl] using the m-values: mN1, mw , mNH, m1H, and mUH as defined 
in Equations 4.1-2 and 4.4-6 to determine the fractions of each species as a function of 
[GuHCl]. 
The equilibrium-unfolding curves for the ferric holoMb variants were also 
obtained at single wavelengths. The amount of helical content was analyzed using 
ellipticity at 222 Dffi. For fluorescence, large emission increases observed at 355 nm 
reflect the loss of hemin, which, when bound in the native folded state, quenches almost 
all Trp fluorescence. For absorbance detection, the unfolding data were analyzed at the 
Soret wavelength maximum of the ferric state for each variant: 409 nm for WT, T67P, 
V68T and H97D, and 393 nm for H64F pentacoordinate metMb. The three detections 
were fit simultaneously according to their respective computed signals from: 
(4.9) 
Fitting ofthe holoMb variants to the six-state mechanism. 
The circular dichroism (CD), fluorescence (F) and Soret absorbance (Abs) signals 
for the unfolding of the holoMb variants were fit to the six-state mechanism using 
Equations 4.1-2 and 4.4-7. The signals from all three detections were simultaneously fit 
using Equation 4.9, and the respective signals for each state were either fixed to values 
obtained from the analysis of apoMb unfolding or allowed to vary. The signal parameter 
values used to generate the fitted curves in Fig 4.2 are listed in Table 4.3 and the 
equilibrium constants for hemin dissociation and m-values are given in Table 4.4. 
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The S(CD) values are different from those used in the analysis of apoMb. In this 
case, the CD222nm of WT apoMb was normalized to 1.0 and is virtually the same for the 
other four variants. The SN(CD) values for the native apoMb states shown in Table 4.1 
were renormalized relative to that for WT holoMb and are in range of 0.47 to 0.71, i.e., 
roughly 60% of the CD of the holoprotein. Similarly, the re-normalized SI(CD) values are 
smaller, - 20-30% of the holoprotein, but still roughly half of that for the apo-N states. 
The CD signal of the IH state, Srn(CD), was allowed to vary but remained in the range of 
that for the apo-I state. The CD signals for the UH state were set equal to zero because 
the population of this species is never significant at the holoMb concentration used 
(Po=lO JAM), whereas Su(CD) for the U state was allowed to vary starting from 0.0. As 
shown both Su(CD) and SUH(CD) are effectively zero. 
For holoMb unfolding, the fluorescence at 355 nm of the apo-U state was 
normalized to 1.0 for each variant. Thus, all the Su(F) values were set to 1.0 and allowed 
to vary but never deviated from this value. The fluorescence signals of the holoMb states, 
SNH(F), were initially set to 0.0, allowed to vary, but never deviated significantly from 
zero. The IH state signal, Srn(F) was found to be higher than expected (i.e., 0.36 to 0.69), 
considering the fact that heme quenches virtually all of the fluorescence of the native 
holoMb NH state. The fluorescence signals of the apo-N and apo-I states were initially 
estimated from analyses of apoMb unfolding fluorescence data measured at 355 nm 
instead of at 341 nm as was done in Table 4.1. The fluorescence of the intermediate state 
is less prominent at 355 nm than at 341 nm. The fitted values of SN(F) are roughly 50% 
of the values obtained from the analysis of apoMb unfolding data due to the change in 
emission wavelength, and the SI(F) values are also smaller for the same reason. The only 
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unexpected results are the large values of Srn(F), which are ..... 50% of the value of the U 
state. As described in the Main Text, we expected that the presence of hemin bound to the 
I state would still result in almost complete quenching. However, that is not the case for 
the intermediate hemichrome species. 
Table 4.3. Respective far-UV CD, Fluorescence emission, and Soret Absorbance Signals used in the fits of 
the holoMb variants to the six-state unfolding mechanism. 
HoioMb WT H64F T67P V68T H97D 
variant 
SNH(CD) 1.00 0.98 1.01 0.99 1.03 
s~cDi 0.60 0.71 0.47 0.63 0.61 
S.(CD)· 0.25 0.46 0.36 0.20 0.25 
Srn(CD) 0.55 0.22 0.25 0.32 0.17 
Su(CD)· 0.03 0.03 0.Q2 0.02 0.02 
SNH(Fi 0.01 0.04 0.00 0.02 0.02 
SN(F) 0.61 0.80 0.82 0.50 0.64 
S.(F) 1.24 1.20 1.46 1.10 1.56 
Su(Fi 0.97 0.96 0.97 0.98 0.99 
Srn(F) 0.36 0.69 0.46 0.53 0.66 
SNH(Abs)3 1.00 1.00 1.02 1.00 1.01 
Srn(Abs) 0.69 0.17 0.20 0.35 0.15 
SH(Abs) 0.03 0.02 0.01 0.01 0.01 
1 The signals for SN(CD), S.(CD), Su(CD) were re-normalized from Table 4.1 assuming SNH(CD) is 1.0 
for WT ho1oMb and SN(CD) is 0.60 for WT apoMb as described in the text above. 
2 The fluorescence signal for the U states were defined as 1.0 experimentally, allowed to vary, and did 
not deviate from this value. The fluorescence signal from the NH state was set to 0.0, allowed to vary, and 
did not change from this value. 
3 SN(Abs), S.(Abs), and Su(Abs) were set to 0.0 because no hemin is bound. The WT SNH(Abs) value 
was initially set to 1.0 (normalized total absorbance change). The other parameters were initially defined 
experimentally and then allowed to vary as described in the text above. 
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The Soret absorbance change for each variant was nonnalized to 1.0 at the 
wavelength of observation. Thus, the signal for the NH state, SNH(Abs), was defined as 
1.0. The signal for free H was set to zero initially, allowed to vary, but, as expected, 
remained effectively at zero since the final state at high [GuHCI] is primarily U+H. The 
S(Abs) values for all the apoMb species are defined and fixed at 0.0. The initial value of 
the hemichrome ill state, Srn(Abs) was set to a value estimated from the model 
hemichrome spectrum shown in Fig. 4.6C and the initial and final spectra shown in 
panels A and B of Fig. 4.6, and then allowed to vary. In general, the fitted values are very 
similar to the initial starting values. The Soret absorbance signal of the UH state, 
Suu(Abs), was initially set to 0.2, allowed to vary, but did not change. There is never any 
significant amount of the UH state even at high [GuHCI], making Suu(Abs) undefined. 
The six-state mechanism is reguired to compare h%Mb variants 
In Chapter 3, we used a four-state mechanism to analyze the equilibrium-
unfolding of holoMb variants, whereas in this Chapter, we have adopted a six-state 
mechanism because the unfolding of apoMb clearly shows the presence of an 
intennediate, even for wild-type protein. To test the need for a more complex model, I fit 
the unfolding curves for the WT and H97D holoMb variants to the simpler four-state 
mechanism (as in Fig. 3.1B). First the apoMb CD unfolding data were fit to a two-state 
unfolding mechanism (not shown) to obtain values for KNUO and mNU, which were: KNUO = 
0.091 and 0.067, and mNU = 1.2 and 1.5 kcal mol- I M- I , respectively, for WT and H97D 
apoMb variants. These fits were poor and could not reproduce the "bell-shaped" 
fluorescence data but were necessary to estimate apoMb unfolding parameters for 
analysis of holoMb data. 
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As expected, the unfolding of WT holoMb can be fit reasonably well to a four-
state unfolding mechanism (Fig. 4.4, upper panels). The distribution of the residuals 
(observed minus calculated signals) indicates that both models can represent the WT 
data, however, as described above, the lack of an intermediate in the unfolding 
mechanism for the apo form argues against using this simpler model. However, the fits in 
the upper panels of Fig. 4.4 for WT holoMb do provide a reasonable estimate for KNHO ... 1 
xlO·14 M with mNH - 6.2 kcal mol-1 M-1• 
In contrast, the four-state model cannot accurately describe the unfolding of 
H97D holoMh. The fits to this simpler model are poor when compared to those to the six-
state (Fig. 4.4, bottom panels). The residuals for the four-state model fits are large and 
systematic, especially for the fluorescence data. However, even with the poor fits, the 
four-state analysis still indicates that the H97D mutant has a much lower affinity for 
hemin than WT Mh, but the absolute value of KNHO is several fold higher than the 
previously estimated value of 2.2 xlO-ll M (Hargrove and Olson, 1996). 
In our view, the four-state mechanism is not appropriate for a thorough 
quantitative analysis of the unfolding curves of the holoMb variants because intermediate 
states are observed with or without bound heme. The three states that populate during 
unfolding of the apo forms are well defined by fluorescence and CD, and the presence of 
an observable hemin-bound intermediate proves that the use of a six-state mechanism is 
required. 
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Figure 4.4. Four-state mechanism for the unfolding of WT and H97D holoMb variants. LEFT: Unfolding 
curves by CD (blue), fluorescence (red), and Soret absorbance (green) for WT and H97D variants, as 
shown in Fig. 4.5. RIGHT: Respective fitting residuals to the 4-state mechanism (open circles) and to the 
6-state mechanism (filled circles connected with lines) , using the same colors as in the left panels. 
Protein concentration 
In general, holoMb unfolding should depend on total protein concentration 
because it involves dissociation of heme, which should be facilitated at low 
concentrations. For this chapter, we focused on resolving whether hemin may bind to the 
intermediate state using the relative differences of apoglobin stabilities and hemin 
affinities between the variants, and thus, we neglected the added complexities of hemin 
dimerization and used a single protein concentration Po= 10 ~M. The addition of a free 
hemin dimerization step after unfolding greatly complicates the analysis, and is described 
in detail in Chapter 5. 
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4.5. Unfolding of WT holoMb 
The agreement between the observed data and the fitted curves is remarkably 
good (Fig. 4.4), considering that the key apoMb unfolding parameters were fixed to the 
values listed in Table 4.2. The fractions of each state during unfolding are also shown in 
Fig. 4.4. The complete set of data for all five variants demonstrates unequivocally that 
unfolding of holoMb is not a one-step process and involves equilibrium populations of III 
and I states at moderate denaturant concentrations. However, as observed previously, the 
curves for WT holoMb by themselves are not definitive with respect to the presence of an 
III state. 
The dissociation constant KNHO for WT holoMb was estimated to be -0.9 x1O·13 M 
at pH 7, 20°C, which is in reasonable agreement with the eqUilibrium dissociation 
constant, K_H -0.3 x1O-13 M, computed from the ratio of association and dissociation rate 
constants for WT metMb at pH 7, but at higher salt concentration in 0.45 M sucrose at 37 
OC (Table 4.2, Hargrove et al., 1996a; Hargrove and Olson, 1996). In addition, we were 
able to successfully estimate KlHo, which is ,...1.4 x1O-11 M, indicating that the hemin 
affinity of the WT I state is ,...100 fold weaker than that of the N state. The value of KUHO 
is poorly defined but estimated to be ,...10-6 M for all five variants, in agreement with 
previous estimates of heme binding to unfolding apoMb and apocytochrome bS62 
(Hargrove and Olson, 1996; Robinson et al., 1997). 
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Figure 4.5. GuHCI-induced equilibrium unfolding of holoMb variants. The left panels represent the 
unfolding data from far-UV CD at 222 nm (blue), fluorescence emission at 355 nm (red), and Soret 
absorbance (green), with the best fit to the six-state unfolding mechanism. The right panels depict the 
population fractions of each species with regards to [GuHCl]. The conditions were: 10 J.tM protein, 10 mM 
potassium phosphate pH 7,20 °C. 
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Table 4A. Hemin dissociation constants and m-values for the NH and IH states of holo-metMb variantsl. 
HoloMb 
KNHo mNH K lHO mlH K.HpH 7-82 K.HpH52 
variant kcal mol· I M·' kcal mol"l M· I (M) (M) (M) (M) 
WT 0.88 xlO·'3 4.4 1.4 xlO·ll 4.0 0.28 xlO·'3 28 xlO·13 
H64F 4.1 xlO·'3 3.5 1.0 xlO·ll 3.3 2.2 X 10.13 130 xlO·13 
T67P 1.0 xlO·13 4.3 3.6 xlO·ll 2.8 n.d. n.d. 
V68T 0.016 X 10.13 4.1 1.5 xlO-ll 3.2 sO.05 xlO-'3 l.l xlO- '3 
H97D 84 xlO-13 3.4 8.8 xlO-ll 2.4 180 X10-13 lloo X 10-13 
I The unfolding measurements were carried out in 0.01 M potassium phosphate pH 7, 20°C. KUHO and 
mUH were fixed to 1.0 xlO-6 M and 2.4 kcal mol"l M·I , respectively, for all five variants. The CD, 
fluorescence, and Soret absorbance signal parameters are given in Table 4.3. 
2 The values for K.H were computed from the hemin dissociation rate constants assuming that the 
association rate constant is 1.0 xlOH M·I S·I for all five variants, as described in Hargrove et ale (1996a). The 
dissociation rate constants were taken from data at pH 7 and pH 5 at 37°C in 0.45 M sucrose and 0.15 M 
sodium phosphate or acetate, respectively (Hargrove and Olson, 1996; Hargrove et al., 1996b). 
4.6. H64F, a variant with increased apoMb stability but decreased hemin affinity 
The unfolding of the H64F mutant is depicted in Fig. 4.5. This mutant was 
selected because the Phe substitution increases the stability of the N state of the apo-form 
by replacing the polar imidazole side chain with a relatively apolar aromatic ring which 
excludes water from the heme pocket (Hargrove et al., 1994a; Quillin et al., 1993). 
However, removal of the distal histidine eliminates the His64 hydrogen bond to the water 
molecule that is coordinated to the hemin iron atom. As a result, water is no longer bound 
to the iron atom, and H64F metMb is pentacoordinate, showing a much weaker Soret 
band at 393 nm instead of the strong 409 nm band seen for the aquomet form of WT 
metMb. In addition, the affinity of the N state of H64F apoMb for hemin is -4-fold 
smaller than that of WT apoMb. In terms of dissociation equilibrium constants, 
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As is observed for WT holoMb, the unfolding curves for H64F holoMb do not 
have obvious inflection points; however, the unfolding curves are clearly broadened and 
the transition midpoints occur at a slightly higher [GuHCI] than those for WT holoMb. 
Fitting to the six-state model suggests the presence of a significant population the IH state 
during unfolding, which causes broadening of the overall unfolding transition. Fitting to a 
two-state model would require a significant decrease in the overall unfolding m-value, 
which is unlikely to be caused by a single point mutation. The larger value of KNHO for 
H64F metMb is in agreement with the larger value estimated from the ratio of the 
dissociation and association rate constants for hemin binding to this mutant (Table 4.4, 
Hargrove et al., 1996b). In contrast, the equilibrium constant for hemin dissociation from 
the mutant IH state, KlHO, is estimated to be 1.0 xlO-11 M, which is similar to that for the 
WT Mb intermediate (Table 4.4). 
The presence of an IH state during unfolding of H64F holoMb is suggested by a 
red-shift of the Soret band to 410 nm at a GuHCI concentration favoring "",50% net 
unfolding. We deconvoluted the UV -visible absorbance spectra of H64F holoMb/GuHCI 
mixtures near the unfolding midpoint to obtain the absolute spectrum of the IH state. The 
result is shown in Fig. 4.6B. Interestingly, the deconvoluted IH spectrum is characteristic 
of a hemichrome species with a Soret maximum at 415 nm, a major low spin t3 band at 
535 nm, and an a band shoulder at 565 nm (Rifkind et al., 1994). Thus, we propose that 
the IH state in Mb is a hemichrome. Unfolding of the heme pocket of the holoprotein 
appears to allow formation of a bis-histidyl linkage to the heme iron even in the absence 
of a distal histidine. Thus, the hemichrome-like IH state may involve bis-His coordination 
by alternative sets of two histidines in the heme pocket region, and not just His64 and 
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His93 (Fig. 4.6) . Alternatively, the bis-axial coordination could arise from a Met/His pair, 
and there is one methionine side chain in the heme pocket region, Met5S(DS). 
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Figure 4.6. Evidence of a hemichrome species as a hemin-bound intermediate. Panels A and B, 
Absorbance spectra for T67P, H64F in the native folded NH, rH , and V + H states. All absorbance values 
were normalized to the peak absorbance of WT metMb at 409 nm at 10 pM total heme, which was the 
concentration used for all the samples. The normalized scale for the visible region, 450 to 700 nm, is 0 to 
0.15 . Deconvoluted spectra, for the IH states were computed assuming the starting NH and fmal V+H states 
shown in the panels and then subtracting weighted sums of these spectra from the spectra measured at the 
midpoint GuHCI concentration where the fraction of IH state is the largest. The fractions of NH, IH, and 
free H at the intermediate GuHCI concentration were estimated from the fitted parameters in Table 4 .4 and 
Equations 4.8-9. Panel C , Overlay of the deconvoluted spectra of the IH states for T67P, H64F, and H97D 
Mb obtained from the GuHCI titrations and the spectrum of imidazole bound to H97D metMb (at 100 roM 
free imidazole). Panel D, spectra for H97D holo-metMb in the absence (solid line) and presence (dashed 
line) of 1.4 M GuHCI, before reduction (black) and after addition of sodium dithionite (gray). The buffer 
conditions were 10 roM potassium phosphate pH 7, 20 °C. 
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4.7. T67P, a variant with wild-type hemin affinity but an unstable N state 
The unfolding of the holo T67P mutant is shown in the middle panels of Fig. 4.5. 
This mutant was selected as a variant with a highly destabilized apoglobin N state (Table 
4.2, largest KN10 value) due to placement of proline in the middle of the E helix (Fig. 4.1). 
However, the affinity of the apoprotein N state for hemin is similar to that of WT Mb. 
The unfolding curves of T67P holoMb all show well-defined inflection points, which 
demonstrate unambiguously the presence of an intermediate species. These data were 
readily fit to the six-state model, and the major intermediate species is the 1H state, which 
dominates at -1.4 M GuHCI. The 1H state for this mutant is favored because of the 
instability of the apoMb N state, which facilitates partial unfolding even with the hemin-
cofactor bound. Analysis of the UV -visible absorbance spectra during unfolding reveals 
directly that the 1H state is a hemichrome-like species, which is characterized by distinct 
absorbance bands at 415, 535, and 565 nm (Rifkind et al., 1994). For this mutant, the 
hemichrome spectrum can be observed almost by itself at the midpoint [GuHCI] value 
because the fraction of 1H is - 0.90 (Fig. 4.5). The deconvoluted spectrum of the 1H state 
for T67P metMb is shown in Figs. 4.6A and 4.6C. 
The fitted parameters for T67P metMb unfolding are listed in Tables 4.3 and 4.4. 
As expected, this mutation does not affect heme affinities, and the computed hemin 
dissociation constants remain similar to those for WT metMb with KNHO -1.0 xl 0.13 M and 
KlHo -3.6 xlO-1I M (Table 4.4). Only the apoMb N-to-I unfolding parameters are affected 
by the T67P substitution (Table 4.2). However, the large increase in KNt causes a marked 
effect on the holoMb unfolding curves and a dramatic increase in the population of the 1H 
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state, allowing its spectral properties to be characterized and assigned unambiguously to a 
hemichrome species. 
4.8. V68T, a variant with increased heme atTmity but decreased stability of the N 
state 
The V68T mutant was selected as a variant with an unstable N apoMb state (i.e, 
increased KN/~ but a markedly increased affinity for heme (Hargrove and Olson, 1996). 
The Thr68 hydroxyl group forms an additional strong hydrogen-bond with coordinated 
water, which stabilizes bound hemin, reduces its rate of dissociation, and decreases KNHO 
markedly (Hargrove and Olson, 1996). 
As is observed for WT metMb, the unfolding curves for V68T holoMb appear 
highly cooperative and indicative of a two-state mechanism, but the holoprotein 
unfolding transition is shifted toward a higher [GuHCI], i.e., .... 2.0 M (Fig. 4.5). Fitting of 
these data to the six-state unfolding model reveals that the increase in transition midpoint 
is caused by an .... 50 fold increase in heme affinity of the N state (KNHO decreases from 
-0.9 to -0.02 XlO-13 M) even though the stability of the N apoprotein state is decreased 
.... 5 fold (KN/ increases from 0.02 to 0.13, Table 4.2). The fits do suggest the presence of 
an IH state during unfolding, but it is present at :S 40% at the unfolding midpoint. We 
were able to deconvolute a hemichrome spectrum at this denaturant concentration, but the 
noise was considerable due to the smaller population of IH and larger amounts of NH and 
V+H states. As is the case for the other mutants, the fitted parameters suggest that the 
affinity of the I state for hemin is similar to that for the WT intermediate with KlHo .... 1.7 
xlO- l1 M (Table 4.4). 
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4.9. H97D, a variant with markedly decreased heme affinity but wild-type apoMb 
stability 
The H97D mutant has a -l00-fold decreased affinity for hemin while retaining N 
and I apo-state stabilities similar to those for WT Mb. The H97D substitution disrupts 
favorable electrostatic interactions between the His97 side chain, the Ser92 hydroxyl 
group on the F-helix, and the heme-7-propionate (Liong et al., 2(01). This disruption 
markedly increases the rate of hemin dissociation and the equilibrium dissociation 
constant (KNH ~ but has little or no effect on the unfolding of apoMb (Fig. 4.2, Table 4.2 
and (Hargrove and Olson, 1996». 
The unfolding curves for H97D metMb (Fig. 4.5) show inflection points, 
demonstrating unambiguously the presence of an intermediate, and the fitted parameters 
show that that the biphasic nature of the curves is caused by population of the IH state, 
which reaches a maximum of -80% at -1.5 M GuHCl. As is the case for the T67P 
mutant, the absorbance spectrum of H97D metMb at -1.5 M GuHCl indicates a 
hemichrome species (Fig. 4.6D). The deconvoluted spectrum for the IH state of H97D 
Mb is shown in Fig. 4.6C, and is identical to that of the IH species for T67P and H64F 
Mb. 
The fitted parameters for H97D holoMb show that the N state has an -l00-fold 
lower affinity for hemin, with KNHO at 84 xlO- J3 M, which is similar to that estimated 
previously from association and dissociation, rate constants for hemin binding to this 
mutant (Table 4.4, Hargrove and Olson, 1996). The affinity of the I state ofH97D Mb for 
hemin is also lower, with K1HO increasing from -1.4 to -8.8 xlO-JJ M. This -6-fold 
decrease in affinity suggests that the unfavorable electrostatic interactions caused by the 
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H97D mutation at the FG comer also weaken the affinity of the I state for hemin even 
though the heme pocket is unfolded. 
4.10. The m state is a hemichrome 
All the Mb variants appear to populate an IH state during unfolding of the 
holoprotein, but the extent varies greatly from :s 20% for WT holoMb to -80 and -90% 
for the H97D and T67P mutants, respectively. The deconvoluted absolute spectra of the 
IH state for the T67P (Fig. 4.6A) and H64F (Fig. 4.6B) variants are shown and compared 
to the starting metMb spectra and the final U state with free hemin. The deconvoluted IH 
spectra of the three variants showing the highest population of IH states are overlaid in 
Fig. 4.6C and compared to that for H97D metMb titrated with excess imidazole (100 
mM, pH 7) to create a bis-imidazole hemichrome in the NH state. All four spectra are 
superimposable and display the low spin peak at 535 nm, the 565 nm shoulder, and the 
red-shifted Soret band at 415 nm, characteristic of a bis-histidyl or a methionyl-histidyl 
hemichrome. 
Surprisingly, the IH species appears to exhibit -40% of the fluorescence of the 
completely unfolded U state even though hemin is still bound. This property is clear for 
T67P Mb (Fig. 4.5). At 1.4 M GuHCI, IH is the dominant species with a clear 
hemichrome UV -visible spectrum, roughly the same CD signal as the I state of T67P 
apoMb (-30% of completely folded holoMb), and roughly 40% of the fluorescence of the 
U state of apoMb. Because, hemin is still bound, we expected that the Trp fluorescence 
would remain almost completely quenched, but it is not. This result suggests that the 
orientations of the dipole moments for fluorescence resonance energy transfer is much 
less favorable than in the native state, expansion of the heme pocket size has moved the 
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porphyrin ring further away from the two Trp side chains positioned along the A helix, 
and/or the enhanced mobility of the Trp residues in this molten globule state reduces both 
solvent quenching and resonance energy transfer. 
4.11. Reversibility of hemichrome formation in Mb 
The hemichromes involved in Hb and Mb degradation have often been associated 
with irreversible protein degradation (Rifkind et aI., 1994). However, the GuHCI-induced 
unfolding curves for holo-metMb are reversible and independent of how the mixtures are 
made. We carried out kinetic experiments in which holoMb at high [GuHCI] was rapidly 
diluted into buffer and vice versa. The same equilibrium state was obtained in each case. 
For example, upon dilution into buffer, the hemichrome IH state of H97D induced by 1.4 
M GuHCI refolds, within the dead time of our stopped-flow apparatus, into the native 
metMb form with a "normal" Soret maximum at 409 nm and visible absorbance bands at 
505 and 630 nm indicative of high-spin aquohemin. 
We also tested whether or not the IH hemichrome in H97D could refold into a 
native-like pentacoordinate deoxyMb state after rapid reduction. As shown in Fig. 4.6D, 
when H97D metMb in 1.4 M GuHCI is reduced anaerobically with a slight excess of 
sodium dithionite, a "normal," pentacoordinate deoxyMb species was formed 
immediately and showed a broad Soret maximum at 434 nm and a single visible 
absorbance band centered at 558 nm. No evidence of a hemochrome (his-imidazole 
complex with heme iron in the reduced state) spectrum was observed under these 
conditions at 1.4 M GuHC1, which Hargrove and Olson (1996) showed is too small to 
induce any denaturation of WT or H97D deoxyMb. Wittung-Stafshede et ai. (1998) 
carried out a similar experiment with native metMb denatured with 2.5 M GuHCI. In 
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their experiment, reduction was induced by photo-excitation of NADH with a 
nanosecond Nd:YAG laser. Almost completely denatured metMb folded into 
pentacoordinate, native-like deoxyMb within 2-3 milliseconds (t:::: 0.3 ms) after photo-
reduction. Thus, the hemichrome IH intermediate appears to be fully reversible and able 
to fold back rapidly into highly stable ferric or reduced NH states. 
4.11. m-values for hemin dissociation equilibrium constants 
In our analysis, we have assumed that all three hemin dissociation constants are 
increased in presence of [GuHCI] and that there is a linear free energy relationship 
between AGO for hemin dissociation and GuHCl concentration, as expressed by Equations 
4.4-6. If KNH were independent of [GuHCI], and the denaturant only affected the apoMb 
unfolding constants as shown in Fig. 4.2, then the computed [GuHCI]1/2 would be -3.5 M 
for WT holoMb, which is markedly greater than the observed value of -1.8 M (Fig. 4.5). 
Thus, it is clear that GuHCl induces hemin dissociation, and the fitted mNH, mlH, mUH 
values help define the steepness and transition midpoint of the holoMb unfolding curves. 
The absolute values of mNH and mlH are unexpectedly larger than those for the N-to-I, and 
I-to-U transitions of apoMb, 4.4-2.4 kcal mol-I M-I for hemin dissociation versus 2.3-1.4 
kcal mol-I M-I for apoglobin unfolding. 
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Figure 4.7. Kinetic traces for hemin loss from H97D aquomet Mb as a function of [GuHC1] . The four 
traces represent normalized absorbance change time courses at 409 nm as a function of GuHCI 
concentration, which is listed beside each curve. In these experiments, 4 ",M H97D aquometMb was mixed 
with 40 ",M H64YN68F apoMb, which acts as a hemin scavenging agent, in 10 mM potassium phosphate 
at pH 7 , 20 °C (See Section 2.4) . INSET: The observed hemin dissociation rate constants were obtained 
from fits to a single exponential process for each trace. A plot of the natural logarithm of these rates versus 
[GuHCI] is shown in the inset. 
To verify the strong dependence of KNH on [GuHC1], we measured the rate of 
hemin loss from H97D metMb as a function of GuHCl concentration in the range from 
0.0 to 0.6 M, and the results are shown in Fig. 4.7. These experiments were carried out 
under the conditions used for equilibrium unfolding (10 mM phosphate pH 7,20 °C) and 
in the absence of sucrose, which is normally added as a stabilizing agent to inhibit 
precipitation of the resulting apoglobin (Hargrove et al., 1994b). As result, the observed 
rate of hemin dissociation from H97D metMb is smaller than that reported previously for 
this mutant in high salt and sucrose at 37°C (Hargrove et aI., 1996b). As predicted from 
the results in Table 4.4, the rate of hemin dissociation depends strongly on [GuHCI], even 
at these low concentrations where little or no net equilibrium unfolding occurs (see 0 to 
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0.6 M [GuHCl] regions in Fig. 4.5). The observed rate of hemin loss from H97D metMb 
increases from -0.15 h·1 atO M to -4 h·1 at 0.6 M GuHCI. A plot oflnk.heminvs. [GuHCl] is 
linear with an apparent m-value for the kinetic free energy barrier to hemin dissociation 
of .... 3.0 kcal mol-I M-I. This value is large and on the order of those obtained for 
equilibrium hemin dissociation from the NH and IH states of this mutant (i.e., mNH -4 and 
m1H .... 3 kcal mol-I M-I, Table 4.4). The agreement between the kinetic and equilibrium m-
values for hemin dissociation appears reasonable considering the difference in type of 
free energy measurement, i.e., equilibrium LlGoversus kinetic LlG* determinations. 
4.12. Relevance of apoMb unfolding to the assembly and denaturation of the 
holoprotein 
The unfolding of apoMb has been studied in great detail over the past 20 years. 
The three-state mechanism is well-established; and the structural nature of the molten 
globule intermediate or I state has been characterized by both mutagenesis and NMR 
approaches (Barrick and Baldwin, 1993b; Hughson et aI., 1991; Jennings and Wright, 
1993; Nishimura et aI., 2006). However the relevance and applicability of these results to 
understand both the assembly and denaturation of holoMb had not been established until 
this work. The key problem is that chemical or thermal unfolding of WT holoMb is a 
highly concerted process, which superficially resembles a two-state process because of 
the high affinity of the N apoMb state for hemin (Fig. 4.5, top panels). In this case, the 
concentration of denaturant required to dissociate hemin from the N state is higher than 
that required to unfold the initial apoprotein N state and the partially unfolded molten 
globule I state. To resolve the role of the apoglobin intermediate in holoprotein unfolding 
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and assembly, we expanded on previous work (Hargrove and Olson, 1996) to include a 
combined analysis of the unfolding of WT and four holoMb mutants. The mutations were 
designed to vary the stability of the apoMb N state and its affinity for heme in order to 
visualize heme binding to the apoglobin folding intermediate. As shown in Fig. 4.5, this 
mutagenesis approach was successful. Our underlying assumption is that the same basic 
six-state mechanism applies to all five variants and that the mutations only affect the 
hemin dissociation and apoglobin unfolding parameters. The success of the fits and 
correlations of the parameter changes with expected structural effects imply that this 
assumption is a good approximation. Thus, one key conclusion is that the well-
established mechanism for apoMb unfolding is directly relevant to holoMb unfolding and 
assembly, particularly when interpreting the effects of mutagenesis on overall stability 
and the appearance of intermediates. 
These results are also relevant to holoprotein assembly in vivo. Graves et ai. 
(2008) and others (Hargrove et aI., 1994a; Scott et aI., 2000; Smith, 2(03) have suggested 
that expression levels of hologlobins in bacteria are proportional to the stabilities of the 
corresponding apoproteins because heme insertion is often limiting when high copy 
number plasmids are used and maximal transcription is induced. Under these conditions, 
the rate of holoprotein production is determined by the rate of heme synthesis or transport 
times the fraction of apoglobin that is folded and competent to bind heme (Graves et aI., 
2(08). One key question in this interpretation is whether heme can bind to the molten 
globule apoglobin intermediate and facilitate formation of the holoprotein. 
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4.13. The IH hemichrome state and holoMb assembly 
Hemichromes have long been associated with irreversible degradation of Hb and 
formation of Heinz bodies in red cells (Rifkind et al., 1994), and presumably similar 
degradation processes occur for Mb in vitro or in myocytes. Our results in Figs. 4.5 and 
4.6 show that sw Mb unfolds via an IH state, which displays the spectrum of a 
hemichrome with a bis-histidyl linkage. The observation of a hemichrome spectrum for 
the H64F variant demonstrates that the distal histidine is not needed to produce the low 
spin IH complex. Thus, the hemichrome spectrum is probably due to a mixture of bis-
imidazole or methionyl/histidyl complexes involving any two of the histidines located in 
the region ofthe heme pocket, His24(B5), His36(C1), His48(CD6), His64(E7), His81(EF 
comer), His82(EF loop), His93(F8), and His97(FG loop) or one of these histidines and 
Met55(D5) (Fig. 4.1). The proposed flexibility of the molten I and IH states appears to 
allow different combinations, although the simplest structural interpretation for most of 
the variants would be axial ligation by the distal and proximal histidines (His64 and 
His93) when they are both present. 
Reversible hemichrome formation is a general phenomenon and is observed 
during either GuHCI or urea-induced denaturation of both sw and horse heart Mb (not 
shown). Hemichrome formation is fully reversible, and the IH state reverts to the native 
metMb form with distal water coordinated to the iron atom upon rapid dilution of GuHCl. 
Similarly, the IH hemichrome does not form a hemochrome when reacted with dithionite. 
Instead, the IH state rapidly converts to a native pentacoordinate deoxyMb form upon 
reduction (Fig. 4.6D), and previous laser induced reduction experiments suggest that this 
process occurs in milliseconds (Wittung-Stafshede et aI., 1998). Our equilibrium results 
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suggest that hemin can bind with reasonably high affinity to the I state, and promote 
formation of the native holoprotein. This pathway for assembly is even more probable 
under micro-aerobic conditions similar to those found in E. coli growing in logarithmic 
phase and, presumably, in respiring myocytes. Under these conditions, free heme still 
rapidly autooxidizes, but reduction of the ferric IH state leads to rapid formation of very 
stable deoxy- or oxy-holoMb states. 
4.14. Hemin binding to the N, I, and U apoMb states 
It was difficult to determine the N and I state hemin dissociation eqUilibrium 
constants accurately without fixing the value of the eqUilibrium constant for hemin 
dissociation from the unfolded state. KUHO is poorly defined in our experiments at lO JlM 
initial holoMb concentration because no significant amount of UH occurs at high 
[GuHCl] (Fig. 4.5). Separate gel-filtration chromatography experiments suggest complete 
hemin dissociation upon unfolding of -lO JlM metMb at [GuHCl] ~ 3 M (not shown). 
Spectra of the Mb variants equilibrated in 3 M GuHCl resemble that of free hemin in 3 M 
GuHCl. We fixed KUHO at 1.0 xlO-6 M in our model based on the affinity constants 
measured for non-specific hemin binding to unfolded apo-cytochrome b562 (Robinson et 
al., 1997) and native bovine serum albumin (Hargrove et aI., 1996a; Marden et aI., 1989) 
and on the estimation that non-specific hemin binding to unfolded apoMb is _lO6 to lO7_ 
fold weaker than binding to the folded N apo-state (Hargrove and Olson, 1996). Fixing 
KUHo to lO-6 M, and KN/ and Kwo to the values determined in separate experiments with 
the apoMb variants, allowed determination of the eqUilibrium dissociation constants for 
hemin binding to the N and I apoglobin states. 
Figure 4.8. Correlation of hemin affmities . The 
correlations are between the hemin dissociation 
15 
equilibrium constant, KNHO, obtained from the 14 
analysis of the GuHCI unfolding curves shown ~ 
in Fig. 4.5 with hemin dissociation equiljbrium 
constants, K H, calculated from the ratio of the Ln 13 
association and dissociation rates constants -c 
measured independently in kinetic experiments ~ 
(Hargrove et aI., 1996a; Hargrove and Olson, ,.... 
1996; Hargrove et al., 1996b). The rate ::I: 12 
parameters are listed in Table 4.4. The open ~ 
circles represent KH values at pH 7-8 and the ~ 
closed, gray circles, KH values at pH 5. The -X 11 
solid lines represent linear fits for -log(KNH ~ ~I 
versus -log(KH) with the slopes and R2 values "ED 
listed beside each set of data. The KNHO values 0 
were measured in 0.01 M potassium phosphate, I 10 
pH 7, 20°C. Most of the KH values were 
obtained from measurements in 0.15 M sodium 
phosphate, 0.45 M sucrose, pH 7.0 or 0.15 M 9 
acetate, 0.45 M sucrose, pH 5 both at 37°C. 
The correlations are very strong, despite the 
differences in conditions. 
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The results in Tables 4.1 and 4.2, and the fits in Fig. 4.5 show that distal pocket 
mutations affect primarily stability of the N state and its affinity for hemin. The 
variations in KNio and KNHO (-1 ,OOO-fold) are markedly greater than those for K lUo and K lHo 
(-6-fold). These results strongly verify Baldwin's, Barrick's, Wright's, and coworkers' 
interpretation (Barrick and Baldwin, 1993b; Hughson et aI., 1991; Jennings and Wright, 
1993; Nishimura et aI., 2006) that the N-to-I, and NH-to-IH transitions involve unfolding 
of the heme pocket to generate a molten globule intermediate with intact A, G, and H 
helices. 
Another key result is that the variation in KNHO values determined by analysis of 
holoMb unfolding curves correspond well with equilibrium hemin dissociation constants, 
K _H' calculated from the ratio of dissociation and association rate constants for hemin 
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binding to the same set of Mb mutants (Table 4.2, last two columns, (Hargrove et al., 
1996a; Hargrove and Olson, 1996; Hargrove et al., 1996b». As shown in Fig. 4.8, there is 
a strong, linear correlation between -log(KNH') obtained independently from unfolding 
curves and the values of -log(KH) determined from kinetic experiments at both neutral 
and low pH. The neutral pH values of KH are poorly defined because the rates of hemin 
dissociation from WT metMb and the other higher affinity mutants are very small and 
difficult to measure. At pH 5, hemin dissociation is more readily measured because of 
increased protonation of the proximal histidine (His93) which promotes breakage of the 
Fe-imidazole bond (Hargrove et al., 1996b). Despite the differences in solvent conditions 
and temperature, both the absolute values of KNHO and the effects of mutagenesis correlate 
remarkably well with the KH values for WT, H64F, V68T, and H97D, determined 
kinetically at both pH values (Table 4.4 and Fig. 4.8). Thus, GuHel-induced unfolding 
curves of holo-heme proteins represent an alternative assay to measure accurately the 
affinities of apoproteins for hemin if the mechanism for unfolding of the apoprotein is 
known. 
Chapter 5 
Influence of hemin dimerization and protein 
concentration on the unfolding of holomyoglobin 
5.1. Introduction 
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Resolving how native holoMb folds and assembles into its native structure is 
more complex than anticipated and requires taking into account: the folding mechanism 
of the apo-form, heme binding to the different apoMb states, the redox state of heme and 
the associated self-associating properties of the free heme cofactor in aqueous solutions. 
Most previous studies have presumed that holoMb unfolds by a one step-transition/two-
state mechanism, despite the presence of a least one intermediate in the folding pathway 
of the apo-form. In Chapter 4, we examined the role of heme in the unfolding of holoMb 
using a set of well chosen Mb variants with properties affecting either the stability of the 
apo-form or hemin binding (Culbertson and Olson, 2010). Our results presented in 
Chapter 4 support previous studies that estimated the affinity of the fully folded apo-state 
for hemin to be ,..,10-14 M (Gibson and Antonini, 1960; Hargrove et aI., 1996a; Hargrove 
et aI., 1996b). More importantly, we were able to estimate the affinity of the apo-
intermediate (I) state for hemin to be ,..,10-11 M, as the unfolding of the met-holo form 
does not proceed via a simple two-state mechanism but rather via a reversible hemin-
bound intermediate which has the spectral characteristics of a hemichrome species (Soret 
band at,.., 416 om, and low spin band at 535 nm with a shoulder at 565 nm). 
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Hargrove and Olson (1996) conducted equilibrium-unfolding experiments on WT 
holoMb and found very little dependence on protein concentration contrary to what 
would be expected if heme were released upon unfolding of the polypeptide chain 
(Modell, Chapter 3, Fig. 3.lA). They attributed the lack of protein concentration 
dependence to non-specific binding of heme to the unfolded polypeptide. The lack of 
protein concentration dependence on apparent stability was also found with ferric 
cytochrome b562 which showed no significant increase in thermal stability upon 
increasing protein concentration (Robinson et aI., 1998). 
It has been known for a long time that hemin (ferric heme) has a propensity to 
self-associate, and recent publications have demonstrated that hemin can form different 
Jt-Jt stacking or f..t-oxo dimers depending on the conditions (Asher et al., 2009; de Villiers 
et aI., 2(07). Thus, the dimerization properties of hemin could also modulate the 
equilibrium unfolding ofholo-globins, as shown in Chapter 3 (Model 3, Fig. 3.lC). 
The effects of protein concentration and the possible influence of hemin 
dimerization are examined in this Chapter for the apo and holo forms of the WT and 
H97D Mh. The H97D variant has a decreased affinity for hemin in the native folded state 
due to the removal of a hydrogen bond network between the imidazole side chain of 
His97, Ser92, and the heme 7-propionate (Hargrove and Olson, 1996; Liong et al., 2(01), 
and strongly populates the IH state during equilibrium unfolding (Fig. 4.5, Culbertson 
and Olson, 2010). Our goal was to determine if a comprehensive analysis of these two 
Mbs could help resolve whether hemin dimerization or hemin binding to the unfolded 
state was the major cause of the lack of protein concentration dependence on holoMb 
unfolding. The expressions for analyzing the holoprotein unfolding curves should apply 
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generally to all hemoproteins and most proteins with relatively insoluble cofactors. The 
details of the analyses build upon conclusions from the simple models in Chapter 3 and 
the complex six-state mechanism described in Chapter 4. 
5.2. Equilibrium-unfolding of WT and H97D apoMb variants 
As in Chapter 4, the analysis of apoMb unfolding is based on a three-state model 
of the apoMb unfolding (Barrick and Baldwin, 1993a; Barrick et al., 1994; Culbertson 
and Olson, 2010; Griko et al., 1988; Nishii et al., 1995; Scott et al., 2000). In this work, 
the buffer concentration was changed from 10 to 100 mM phosphate to mimic more 
closely the cellular conditions (ionic strength and osmolarity). The stability parameters 
KN/ and K lUO for the N-to-I and I-to-U transitions of the apoMb variants were needed for 
analysis of the holoprotein unfolding. Thus, both WT and H97D apoMb variants were 
titrated with GuHCI, and the unfolding was followed by far-UV CD and fluorescence 
emission. As in Chapter 4, the CD data at 222 nm alone do not allow for an accurate 
measure of the amount of intermediate present. The latter species is revealed by the 
fluorescence emission data at 343 nm as the hyperfluorescence peak in the bell-shaped 
curve. The wavelength at which maximal emission intensity occurs is red shifted by 2 nm 
as a result of the increase in phosphate concentration. The unfolding data from both 
detection data were analyzed using a global fit, again assuming a simple three-state 
scheme. 
The eqUilibrium unfolding curves were successfully fit to the three-state 
eqUilibrium unfolding mechanism (Fig. 5.2) and the KN/ and K lUO stability constants for 
the N-to-I and I-to-U transitions are shown in Table 5.1. As expected, the H97D mutation 
does not significantly affect the stability of the N and I states of apoMb, as His97 is a 
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surface residue, already solvent exposed in the folded apo form. The increase in 
phosphate concentration from 10 to 100 mM did however increase the overall stability of 
the two apoMb variants by a factor of -2 to 3 (as stability constants) which corresponds 
to a free energy increase of 0.4 to 0.6 kcal mol-I. Phosphate and potassium ions are part of 
the Hofmeister series, which are known to decrease the solubility of hydrophobic 
residues and therefore strengthen hydrophobic interactions (Baldwin, 1996), which in 
apoMb help the hydrophobic core to resist denaturation. This effect was also noticed in a 
previous study on apoMb variants (Smith, 2003), and appears to be relevant to all 
apoglobins. The 10-fold increase in buffer concentration also affected the fluorescence 
intensities of the intermediates for both (Figs. 4.2 and 5.1). 
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Table 5.1. Stability parameters for equilibrium unfolding of apoMb variants l 
ApoMb variant 
WT 0.016 0.011 5400 
H97D 0 .017 0 .012 4800 
I The GuHCI-induced unfolding measurements were carried out in 100 mM potassium phosphate pH 7 , 
20°C. The KNlo and KlUo were obtained by fitting simultaneously both CD and Fluorescence signals for the 
unfolding of the apoMb variants to the three-state unfolding mechanism using Equation 4.3 (Appendix 
AA). The values of m N1 and m lU were set to 2.35 and 1.36 kcal mor l M·I , respectively. 
5.3. A six-state mechanism with hemin dimerization for the unfolding of holoMb 
The equilibrium-unfolding mechanism described in Chapter 4 was used to 
investigate the unfolding of WT and H97D Mb variants in the aquomet form with the 
addition of hemin self-association and variation of protein concentration. 
IH KIH ~ I + H ~ Figure 5.2. Six-state model for the unfolding 
of holoMb based on the three-state unfolding 
mechanism of apoMb, the assumption that 
heme can bind to all three apoMb states, and 
that heme self-dissociates . 
K/U 
UH 
K UH 
> U + H ~ 
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The model shown in Fig. 5.2 was applied to the unfolding curves for each holoMb 
variant. In this equilibrium model, the KN/ and KlUo stability constants and mNl and mlU 
values for the N-to-I, and I-to-U transitions of apoMb were determined independently in 
separate experiments with the apo-forms. The heme dissociation constants from all 
possible heme-bound states, NH (metMb), IH, and UH were allowed to vary in order to 
define the equilibrium unfolding curves for holoMb. The hemin dimerization constant is 
defined as: 
K = _[H_2_] ... KO exJ_m_H ..... £_G_UH_C_l]) 
H2 [H]2 H2 \ RT (5.1) 
The population fractions of each species were computed by first obtaining the free 
concentration of heme [H], which can be computed by finding the appropriate root of the 
following cubic function: 
a[H]3 + b[H]2 + c[H] + d (5.2) 
where: 
(5.3) 
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The derivation of Equation 5.3 is given in the Appendix A.6. The fraction of each 
species was calculated using the free heme concentration [H], the two apoMb stability 
constants, and the three hemin equilibrium dissociation constants as shown beneath for 
the NH state: 
(5.4) 
Each of the stability and affinity constants in Equation 5.4, were computed at 
different [GuHCI] using the m-values: mN1, m/U, mNH, mlH, and mUH, as defined in 
Equations 4.1-2 and 4.4-6 to determine the fractions of each species as a function of 
[GuHCI]. 
The Soret absorbance and far-UV CD signals were computed from: 
The two detection methods, CD, and Soret absorbance, used for analysis of the 
equilibrium-unfolding of ferric holoMb variants, were analyzed at single wavelengths, 
222, and 409 nm, respectively. Unfolding curves were determined at three protein 
concentrations, 2, 10, and 100 !J.M. The use of fluorescence detection was not possible 
due to the high range of protein concentrations and subsequent absorbance at 280 nm. 
The unfolding data sets for the two detection methods at the three protein concentrations 
were simultaneously fit using an algorithm coded in C for use with Gnuplot 
(http://www.gnuplot.infol) and based on the unfolding mechanism in Fig. 5.2. The full 
source code is provided in the Appendix A.tO. 
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SA. Equilibrium-unfolding of WT and H97D holoMb variants 
Even though WT aquomet holoMb appears to unfold in an apparent two-state 
equilibrium mechanism at neutral pH, we have shown that a small amount of a 
hemichrome IH state is populated near the GuHCI midpoint at lO IlM (Chapter 4, Fig. 
4.5, and Culbertson and Olson, 20lO). The H97D mutation was designed to demonstrate 
unequivocally the presence of a hemin-bound intermediate even at low protein 
concentration (Po= 10 IlM). The difference in the unfolding curves of WT and H97D 
ferric Mb (Fig. 4.5) do not arise from the unfolding properties of the apo forms but from 
the large decrease in hemin affinity of the H97D mutant when compared to WT Mb (See 
Chapter 4). 
The equilibrium-unfolding data for both CD and Soret absorbance detections at 
the three protein concentrations for WT holoMb are shown in Fig. 5.3. The data were fit 
using a comprehensive algorithm to interpret simultaneously the six unfolding curves. 
We estimated the KNHD and KlHD values to be 7.4 XlO-14 and 1.2 xlO- ll M, respectively. The 
KNHD and KlHD values for the H97D variant were estimated to be 1.5 XlO-12 and 1.5 xlO-ll 
M (Fig. 5.4). As expected, the fitted dissociation constants for hemin dissociation from 
the NH and IH states were little affected by free hemin dimerization when compared to 
the values reported in Chapter 4 where free hemin was assumed to remain monomeric. 
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Figure 5.3. Equilibrium unfolding of WT sw holoMb at different globin concentrations. A. Unfolding data 
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of the NH (black), IH (orange) and UH (blue) holo states. D. Population fractions of H (gray) and H2 
(black). The CD data is depicted in blue, the Soret absorbance in red. Conditions: 100 mM potassium 
phosphate pH 7, 20°C. 
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The new fits reveal that increasing protein concentration favors the IH state while 
decreasing population of the apo-I state. Even though the fits are not perfect, this analysis 
does show that the lack of protein concentration dependence of the unfolding curves is 
mainly due to hemin binding to the I state and that the "extra" Soret absorbance phase 
observed at high [GuHC1] is probably due to hemin dimerization after protein unfolding 
is complete. The deviations of the fits to the Soret data are probably a result of 
uncertainties regarding the exact aggregation state of hemin in GuHCl solutions. 
5.5. Effect of protein concentration on formation of the m hemichrome and I 
states 
In principle, hemin dissociation should be favored a low concentrations, and 
increasing Po would favor the hemin bound states, NH, IH, and UH. At high [GuHC1], the 
U state does not bind hemin with high enough affinity to retain hemin at 
spectroscopically detectable levels even at high protein concentration. However, the I 
state can specifically bind heme and the IH hemichrome state is readily detectable and 
markedly affects the measured unfolding curves. Increasing protein concentration favors 
the IH state and enhances resistance to hemin loss and complete unfolding. The net result 
is that the hemichrome state is much more readily populated and detected at high globin 
concentrations. 
The unfolding curves for both WT and H97D holoMb variants are shown in Fig. 
5.3, and as predicted by the scheme in Fig. 5.2, the presence of the IH state is 
significantly more favored at tOO JAM than at 10 or 2 JAM total protein. In addition, these 
analyses show that the population of the IH state is greater at the higher too mM 
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potassium phosphate concentration used in these experiments than the 10 mM 
concentration used in Chapter 4. This effect is particularly evident for WT holoMb. 
The effect of the denaturants GuHCI or urea on the self-association properties of 
hemin have not been reported previously. Our preliminary results using the absorbance 
characteristics of hemin suggest that hemin dimerization is little affected in solutions 
containing chemical denaturants (GuHCI and urea). Equation 5.1 assumes that GuHCI 
exponentially influences the hemin self-association constant. In Chapter 3, we 
investigated the possible cause for the lack of protein concentration dependence on the 
apparent stability of monomeric globins. The addition of a hemin dimerization step alone 
could explain part of the lack of protein concentration dependence of the unfolding 
curves of globins (Chapter 3, Fig. 3.1C). GuHCI-induced hemin self-association (i.e., a 
positive mH2 value) would facilitate dissociation of hemin at high protein concentration 
and compensate the expected stabilization of the NH and IH states at high holoMb levels. 
The net result of a positive mH2 value would be less protein concentration dependence on 
the apparent unfolding curves. In contrast, a negative mH2 value would increase the 
protein concentration dependence. The fits in Figs. 5.4-5 suggest a negative mHz value (--
1.2 kcal mol·1 Mol) for hemin dimerization so that at high [GuHCI], free hemin remains 
monomeric. However, the effect of [GuHCI] on hemin dimerization is small and not a 
major determinant of the holoMb unfolding curves except for the absorbance changes 
associated with the hemin dimerization at high holoMb concentrations. 
5.6. Lack of apparent protein concentration dependence on equilibrium 
unfolding of monomeric globins 
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Varying protein concentration is a useful tool in analysis of the folding of 
multimeric or cofactor-proteins. Mathematically, increasing the concentration of a 
multimeric protein stabilizes it against dissociation and unfolding as illustrated by 
Equation 1.1. Cofactor-proteins also gain stability against dissociation of the cofactor and 
unfolding at elevated protein concentration. 
In Mh, the lack of protein concentration dependence on apparent stability was 
fIrst observed by Hargrove and Olson (1996) and was attributed to hemin remaining 
bound non-specifIcally to the unfolded polypeptide. To test this assumption, I used a gel 
fIltration assay to determine whether hemin would separate from holoMh, unfolded in 3 
M GuHCI (data not shown). Despite hemin eluting separately from unfolded apoMb, the 
results were inconclusive as hemin can also interact readily with sugar polymers that 
make up the gel fIltration media. However, the assay did prove that the hemin affinity of 
the U state is quite weak. The unfolding simulations in Fig. 3.1 showed that hemin 
dimerization upon dissociation from the unfolded globin could also be a governing factor 
for the lack of protein concentration dependence on apparent stability. It is unlikely that 
hemin remains attached to unfolded Mb in vitro at high denaturant concentrations, as 
GuHCI markedly weakens the affinity of the apoMh states for hemin. It was shown that a 
fly-casting mechanism is probably not governing the assembly of Mb in vivo because 
folding is not accelerated in the presence of dicyano-hemin in vitro (Crespin et al., 2005). 
Our analyses show that it is important to understand how denaturants influence 
the affinity of a protein for a cofactor to avoid bias in analyses of unfolding data. The 
99 
dependence of hemin affinity on [GuHC1] is shown in Chapter 4, Fig. 4.7, and the fits to 
unfolding data for holoMb variants in Fig. 4.5 show that the unfolded states do not 
possess high enough affinity to retain hemin at [GuHCI] favoring complete unfolding. 
Hence, it is unlikely that hemin binds to the U state prior to folding, but the results in 
Figs. 4.5 and 5.3-4 demonstrate that the apoMb intermediate possesses a hemin affinity 
high enough to occur during refolding, and it seems very likely that the IH state is 
probably on pathway for assembly in vivo. Thus the lack of protein concentration 
dependence on the observed unfolding curves for holoMb is primarily due to hemin 
binding to the I state (Figs. 5.4-5). 
5.7. Effect of potassium phosphate concentration on unfolding of hologlobins. 
Our previous analysis was done at low buffer concentration. In this work, the 
phosphate concentration was increased to 100 mM to mimic the ionic strength and 
osmolarity in cells. To investigate the effect of buffer concentration more directly, the 
dependence of the rate of hemin loss from aquomet H97D sw Mb on potassium 
phosphate concentration was measured (Fig. 5.5). Interestingly, increasing the buffer 
concentration from 10 to 300 mM accelerated the rate of hemin loss more than 2-fold. 
As described earlier in this chapter, the increase in phosphate concentration 
stabilizes the apoMb variants, decreasing KN/KIUO by a factor of 2 to 3.1f we consider the 
stability of the NH state to be roughly represented by 1I(KNHOKN10KIU~' it appears that the 
stabilizing effects on the apoprotein with increasing ionic strength are almost exactly 
compensated by a weakening effect on hemin affinity. More experiments are needed to 
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determine if this is specific to phosphate or simply an ionic strength effect. 
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Figure 5.5. Dependence of 
[phosphate] on rates of hemin 
loss from H97D sw Mb. Hemin 
loss was induced upon addition 
of the apo reagent (H64YN68F 
Mb) and the concentration of 
phosphate was varied from 10 
to 300 mM at pH 7, 20°C . 
The addition of a hemin dimerization step in the unfolding model for holoMb 
renders the analysis of unfolding data deceivingly much more complex. Investigating 
unfolding at three protein concentrations allows for a more accurate determination of 
hemin affmity constants. Due to the uncertainties in spectral assignments for the free 
hemin aggregates, it was difficult to accurately fit the last phases of the unfolding curves. 
However, the major phases of these curves were readily analyzed to accurately estimate 
the affinity constants. This detailed analysis demonstartes that hemin binding to the I 
state is the main cause for to the lack of protein concentration dependence on apparent 
stability of holoMb. 
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Chapter 6 
Cerebratulus lacteus Hb, a simpler system 
6.1. Introduction 
As a control for the mechanistic approach developed for sw Mb, we looked for a 
simpler model globin system. The neuronal miniglobin from Cerebratulus lacteus 
(termed CerHb) was chosen for several reasons. First, this small globin lacks an A-helix, 
which is one of the main structural components of the molten globule intermediate found 
in sw apoMb. Second, the stability and folding characteristics of CerHb had not been 
measured previously. Third, our laboratory already had well-established protocols for 
expressing and purifying large amounts of CerHb. Fourth, this miniglobin should be a 
simpler system, in which the unfolding of the apo- and holoprotein could be interpreted 
using one of the simple unfolding mechanisms presented in Chapter 3. The key was to 
test the generality of the analysis developed for holoMb unfolding and perhaps establish a 
simpler model system for globinlheme assembly. 
6.2. Stability of the WT apoCerHh 
The extraction of the heme cofactor from ferric CerHb and proper refolding of the 
apoprotein was possible using the methyl ethyl ketone method (See Chapter 2). Then, 
WT apoCerHb was titrated with GuHCI at 20°C as described previously for apoMb 
variants in Chapters 4 and 5 (Fig. 6.1). WT apoCerHb in the folded state does possess a 
typical a-helical far-UV CD spectrum, but has about half of the molar ellipticity of 
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apoMb. Fluorescence measurements of the apo form rely on emission form the Trp3 (at 
the beginning of the B helix) and four Tyr residues that are mostly buried in the folded 
state. Upon addition of GuHCI, fluorescence emission decreases due to unfolding and 
solvent exposure of the fluorophores, and the emission peak shifts from 333 to 354 nm. 
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Figure 6.1. GuHCI-induced equilibrium 
unfolding of WT apo-CerHb, monitored by 
Far-UV CD222 (blue), and Trp fluorescence at 
333 nm (red). Lines represent the best fits to 
the a two-state unfolding mechanism with a 
post-transitional baseline. 100 mM phosphate 
pH 7,10 f.lM, 20°C. 
WT apoCerHb does unfold by a two-state mechanism as suggested by an overlap 
of the fluorescence and CD curves, and the lack of an inflection point. Fitting to a two-
state equilibrium mechanism (N to U) with a post-transitional baseline showed that 
apoCerHb is quite unstable at 20 °C, with a KNUO of 0.127, and a m-value for the 
unfolding, mNU ' of 2.46 kcal mol-I M-I. This mNU value is smaller than the combined m-
values for the unfolding transitions of apoMb, which is in agreement with its decreased 
size (Auton et aI., 2007). 
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6.3. Four-state analysis of the equilibrium unfolding of holoCerHb 
Figure 6.2. Four-state mechanism for the 
unfolding of holoCerHb. KNU is the stability 
constant between the Nand U apo states, 
and K NH and K UH represent the equilibrium 
constants for hemin dissociation from the 
native NH and UH states, respectively. 
K UH UR -=:::;;,-=========.ha. U + H 
The four-state mechanism shown in Fig. 6.2 was used to investigate unfolding of 
WT holoCerHb. The equations for this mechanism are described in Chapter 3 and the 
appendix (Fig. 3.1B, A.2). Unfolding of WT aquometCerHb was induced by addition of 
GuHCI and monitored by far-UV CD, and Soret absorbance. The overlays of the 
unfolding curves are shown in Fig. 6.3. Fits to the unfolding data estimate the equilibrium 
dissociation constant for hemin dissociation from the apo-N state, KNHO, equal to be "-' 
1.2xlO·1O M. In addition, the mNH value was estimated to be ,,-,6.2 kcal mol-1 M-1, higher 
than the estimated mNH values for the sw Mb variants in Chapter 4 (Table 4.2). 
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Figure 6.3. GuHCI-induced equilibrium-
unfolding of WT holoCerHb, monitored by far-
UV CD222 (blue) and Soret absorbance at 406 nm 
(green). Lines represent the best fits to the four-
state unfolding model. KNHO= 1.2x 10-10 M and 
mMF 6.2 kcal mor l M-l . Conditions: 10 !-lM 
globin and 100 mM phosphate pH 7 at 20°C. 
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6.4. Dependence of [GuHCI] on the rates of hemin loss from WT aquomet CerHb 
The large dependence of GuHCl on the rates of hemin loss from aquomet Mb is 
described in detail in Chapter 4. We tested whether these high mNH values are inherent to 
the release of hemin from all monomeric globin by examining the dependence of rate of 
hemin loss from metCerHb on [GuHCl] . The absorbance spectrum for aquomet CerHb is 
similar to that of WT aquomet Mb, which again allowed the use of H64YN68F apoMb 
(See Chapter 2.2) to displace hemin from ferric CerHb and measure the rate of hemin loss 
from the invertebrate Hb. As expected, WT CerHb loses hemin at a much greater rate 
(,..,().2 h-'), 20 °C, than WT Mb (-0.01 h-') at 37 °C (Hargrove et aI., 1996b), and hemin 
loss is greatly accelerated at higher temperatures. The absolute value of k" is similar to 
that from H97D Mb variant (- 0.15 h-') at 20 °C. GuHCl dramatically increases the rate 
of hemin loss from CerHb as in Mb, and the apparent mNH value is large and comparable 
to that of H97D sw met-Mb. Thus, the high values of mNH appear to be inherent to hemin 
dissociation from all globins. 
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Figure 6.4. GuHC1-dependence of hemin loss 
rates from 4 I-lM WT aquomet CerHb using 40 
!AM H64Y/V68F apoMb. Main panel depicts 
the nonnalized absorbance decrease at 406 nm 
in 0,0.1,0.2,0.3, and 0.4 M GuHCl. The inset 
depicts the natural logarithms of the rates as a 
function of GuHCl. 100 mM phosphate pH 7, 
20°C. 
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Figure 6.5. Space-filling representation of WT CerHb (upper panels) and WT sw Mb (lower panels) . The 
heme is shown in light gray, hydrophobic residues in green, basic residues in blue and acidic residues in 
red. The left and right panels depict the same globin, but are rotated axially around the heme molecules . 
Images created using PyMol and the PDB entries: lk:r7 (CerHb) and Ijp6 (sw Mb). 
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6.5. Conclusions 
Our results show that the apo-fonn of CerHb unfolds by a two-state mechanism 
and that a four-state unfolding model may be used to interpret the unfolding of the holo-
protein (Fig. 6.2). The estimated value for KNHo is higher than expected, with the hemin 
affinity "'"' 1300 fold weaker than that of WT sw Mb. Aquomet CerHb loses hemin at a 
rate comparable to that sw H97D Mb which is O! 500 times faster than hemin loss from 
sw WT Mb (Hargrove et al., 1996b). CerHb is significantly smaller than Mb and appears 
to have a less protected apolar pocket for hemin binding (Fig. 6.5), perhaps accounting 
for higher rate of hemin dissociation. The mNH value obtained from the GuHCI 
dependence of rates of hemin loss is comparable to those for the metMb variants, which 
suggests that the m-values for the equilibrium hemin-dissociation constants reflect an 
inherent property of GuHCI interacting with free hemin and the corresponding 
apoglobins. In addition, the lack of a populated I or IH state is supported by the lack of 
any observable hemichrome fonnation. Thus, CerHb can serve as a simple globin model 
system for unfolding and assembly. 
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Chapter 7 
The unfolding of human hemoglobin A 
This chapter is adapted from: 
Culbertson, D.S., and Olson, 1.S. (2010). Folding and Assembly of Myoglobins and 
Hemoglobins. In Protein Folding and Metal Ions: Mechanisms, Biology, and 
Disease, P. Wittung-Stafshede, and C.M. Gomes, eds. (Taylor and Francis, Inc.) 
pp.97-122. 
7.1. Introduction 
The exact assembly pathway for heterotetrameric HbA has remained unresolved. 
Possible mechanisms are explored in this Chapter starting with the scheme for the 
unfolding of the u l 131 apoHb dimer, and followed by measurements of holo-metHb 
unfolding that show the appearance of hemichrome intermediate identical to those 
observed during holoMb denaturation. 
7.2. Theoretical investigation of the folding mechanism for the u 1131 apoHb dimer 
Removal of heme from native HbA generates an u l 131 apoHb dimer. The 
unfolding of this dimer into denatured monomeric subunits can occur by several 
mechanisms. The three most likely pathways for unfolding are shown in Fig. 7.1. For 
simplicity, the u and 13 subunits are assumed to have similar properties. 
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Figure 7.1. Equilibrium-unfolding mechanisms for the <l1f3( apoHb dimer. Possible unfolding mechanisms 
for apo-Hb dimers and simulations of GuHCI-induced equilibrium unfolding based on these mechanisms. 
D, ID , N, 1 and U represent the dimer, dimer intermediate, native, intermediate and unfolded states. Upper 
panel, Scheme A. Model in which the apoHb dimer dissociates and unfolds in one step. K2U,D = 6.25 xlO JO 
M-l , m 2U,D = 7.2 kcal mol-( M-I Scheme B. Model in which the dimer unfolds to two folded states followed 
by partial unfolding to an intermediate 1 and then complete unfolding. K2N.D = 1.0 xl 08 M-I, m 2N,D = 0.5 kcal 
mol-( M-I, KIJ~= 5, ml.N= 2.2 kcal mol-) M-I, KVJ= 5, mUJ = 1.2 kcal mol-I M-I. Scheme C. Model involving a 
partially folded dimer intermediate and then dissociation into unfolded monomers. K/D ,D = 100, mm,D = 4.3 
kcal mol-I M-I, KlUJD = 6.25 x108 M-( and m 2UJD = 2.9 kcal mol-( M-I. The K and m-values in all three models 
were set to estimated values that, were mathematically equivalent and gave mid-point GuHCI 
concentrations similar to those observed in experiment by Graves et al (2008) at 5 °C, pH 7 for Po ,..,3-10 
pM. The <l and f3 subunits were created with PyMol and PDB structure lird and, for these mechanisms , are 
assumed to be equivalent in stability. Lower panel, Simulations for the unfolding of the apoHb dimer 
according to three models depicted in panels A, Band C, respectively. Protein concentration was varied 
from 1 (dotted) to 20 (dashed) to 400 (solid line) ~M. Equations for aU three models are given in the 
Appendices A.7-9. Note, the constants are folding , not unfolding constants . 
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In mechanism A, the dimer is assumed to unfold and dissociate into unfolded 
monomers in a single concerted process (Fig. 7.1A). In mechanism B, the dimer 
dissociates into folded monomers, which in turn unfold via a monomeric intermediate 
into completely unfolded monomers (as observed for apoMb, Fig. 7.1B). In mechanism C 
the dimer first unfolds to an intermediate with -50% loss of helicity, but with the 
subunits still associated by the al~1 interface. Then, this dimeric I state dissociates into 
completely unfolded monomers (Fig. 7.1C). Because dissociation into monomers occurs 
in each case, all three apo-dimer mechanisms predict a strong dependence on total protein 
concentration, with increased resistance to unfolding at high Po. Derivations of 
expressions for the unfolding curves predicted by each mechanism are given in the 
Appendix A.7-9. These equations were used to simulate GuHCl-induced unfolding 
curves as a function of total protein concentration, Po, and results for 1, 20, and 400 pM 
apo-Hb subunits are shown in Fig. 7.1. 
The unfolding curves predicted by mechanism A are steep, as expected for a 
simple two-state mechanism (i.e., D or 2U), and show a marked right-shift to greater 
stability at higher protein concentrations. Although more complex with four states, 
mechanism B also predicts steep unfolding curves if reasonable values of the folding 
parameters are used. In this mechanism, the major resistance to unfolding is dimer 
dissociation into the much less stable monomers, which unfold completely at the 
denaturant concentrations required to disrupt the interface of the original apoHb dimer. 
Again, a strong dependence on protein concentration is predicted. In contrast, mechanism 
C predicts broad unfolding curves, which become biphasic at high protein concentrations. 
In this case, the initial step involves a unimolecular conformational change, which is 
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independent of protein concentration because the dimer remains intact. The second step 
in mechanism C is bimolecular involving dissociation into unstable monomers, which is 
markedly inhibited at high protein concentrations. 
Preliminary data collected by Philip E. Graves (Graves, 2(08) indicated that 
apoHb dimers show broad unfolding curves, which begin to show two distinct phases of 
roughly equal amplitudes at high apoHb concentrations. These data suggest that 
mechanism C applies to apoHbA. The simplest structural interpretation is that, like 
apoMb, initial addition of denaturant causes unfolding of the heme pocket and its 
associated B, C, D, and E helices, whereas the A, G, and H helices remain intact in both 
the a and f3 subunits, preserving most of the a lf31 interface, which involves helices B, G, 
and H in the intact Hb tetramer. Further addition of denaturant simultaneously disrupts 
the dimer interface and unfolds the A, G, and H helices leading to completely unfolded 
subunits. Preliminary efforts were made to repeat these equilibrium-unfolding 
experiments with native apoHb dimers. These initial experiments gave results similar to 
Graves data, but the intrinsic unstability of apoHbA causes large problems with 
variability in the data at low [GuHCl] and precipitation at high protein concentrations. 
More work is needed to construct more stable HbA mutants that will allow more detailed 
experimental analyses. However, our theoretical analysis is new and novel, and likely to 
be applicable for future analyses. 
7.3. Presence of hemichrome state in the unfolding of metHbA 
The presence of bi-histidyl hemichrome adducts is well documented in 
hemoglobinopathies or thalassemias (Asakura et al., 1977; Bank et aI., 1985; Kan, 1985; 
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Weiss et aI., 2005; Winterboum and Carrell, 1974). Hemichromes are notably observed 
in Hb aggregates of Heinz bodies (intra-erythrocytic aggregation of denatured Hb) as 
reviewed by Winterboum (1990) and have been linked to denatured globins for over 50 
years (Falbe-Hansen, 1961) (Fig. 7.2). These hemichromes were identified spectrally in a 
and f3 thalassemia erythrocytes and were considered to be Hb states that were irreversibly 
denatured (Asakura et aI., 1977; Bunn and Forget, 1986). 
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Figure 7.2. Degradation pathway 
for HbA. Adapted from 
(Winterboum and Carrell , 1974) . 
More recently, hemichromes have been shown to be naturally occurring 
hexacoordinate states of Hbs from several vertebrate species including neuroglobins and 
cytoglobins (Kakar et al., 2010; Mitchell et al., 1995; Vergara et al., 2009; Vergara et al., 
2007; Vergara et al., 2008). In adult humans, hemichromes are believed to be on the 
degradation pathway of HbA once oxidation has occurred (Arnold et aI., 1999; 
Rachmilewitz et al., 1971; Winterboum and Carrell, 1974). In Chapter 4, we have 
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provided evidence that GuHCI-induced hemichromes are reversible in sw Mb, and that 
they are on the pathway to globin assembly. In contrast, we were not able to "find" a 
hemichrome species during the unfolding of holoCerHb, which does not show an 
intermediate during unfolding of its apoglobin form. Thus, hemichrome formation 
appears to be associated with hemin binding to an intermediate (I) state with the heme 
pocket unfolded. 
As a further test of these ideas and to search for intermediate folding states in 
HbA, we examined GuHCI-induced eqUilibrium unfolding of native aquomet HbA at 10 
and 100 f.A.M concentrations. As in previous chapters, unfolding was followed by CD, 
UV-visible absorbance, and in some cases, fluorescence emission changes. 
The presence of a reversible hemichrome state during unfolding of metHbA is 
clearly evident from the visible-absorbance spectra. The Soret band red-shifts to 414-415 
nm, and there is a strong appearance of the characteristic low spin bands at 535 and 565 
nm (Fig. 7.3). Hemichrome species are strongly present even at concentrations of 10 f.A.M 
HbA on a per heme basis, and increasing the metHb concentration to 100 f.A.M increases 
popUlation of the hemichrome species. The dimerization of hemin is also apparent at 100 
f.A.M metHb, with the appearance of a 370 nm band (Fig. 7.3). 
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Figure 7.3. GuHCI-induced equilibrium-unfolding of native human aquometHbA monitored by UV -visible 
absorbance. The 10 and 100 11M of HbA concentrations are depicted in the left and right panels, 
respectively. The absorbance signals were normalized, and the absorbance scale from 450 to 700 nm is 
amplified 7-fold. The presence of the hemichrome is noticeable with the dual 535-565 nm band. 
Conditions: 100 mM potassium phosphate pH 7,20 °C. 
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Figure 7.4. Deconvoluted absorbance spectra of native aquometHbA species present during equilibrium-
unfolding. Three species are observed in the GuHCI titrations shown in Fig. 7.2: native (blue), hemichrome 
(red) and free hemm in 4 M GuHCI (green and purple). The spectra were normalized to 1 based on the 
native signal for aquometHbA. The purple and green curves depict the spectra for the unfolding endpoints 
at 10 and 100 11M globin concentration on a per heme basis, respectively. The 450 to 700 nm range is on a 
0-0.15 absorbance scale. 
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Only three species appear to be responsible for the overall absorbance spectra in 
Fig. 7.3: native metHb, a hemichrome intermediate, and hemin (Fig. 7.4). The 
hemichrome species is readily observable with a Soret band at 416 nm, and the 
characteristic low spin 535-565 nm bands (red spectrum, Fig. 7.4). The spectra at 4 M 
GuHCI are different at high versus low protein concentration (green vs. purple spectra in 
Fig. 7.4), as observed by the increase in absorbance at 370 nm at 100 !J.M HbA. 
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Figure 7.5. Deconvolution of the populations of the three-states present during equilibrium-unfolding of 
native aquometHbA. The unfolding was induced by addition of GuHCI and the process was followed by 
UV -vis absorbance. The deconvolutions were based on the equilibrium-unfolding depicted in Fig. 7.3 and 
on three observable states: native (black), hemichrome (green) and hemin with unfolded apoHb chains 
(red). The 10 and 100 !AM concentrations are shown in filled circles and squares, with dashed and solid 
lines , respectively . Conditions: 100 mM potassium phosphate pH 7, 20°C. 
In an attempt to understand how HbA unfolds, I determined the fractional amount 
of each of the three species from the absorbance spectra at each GuHCI concentration 
using the standards in Fig. 7.4 for native metHbA, the hemichrome, and hemin. The 
fractions of each spectral species during unfolding are shown as a function of [GuHCI] in 
Fig. 7.5. The hemichrome species dominates at -1.6 M GuHCI at both protein 
concentrations, but persists longer at the higher HbA concentration. Mechanistically, this 
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suggests that hemin dissociation occurs during unfolding of the hemichrome state, which 
should be inhibited at higher HbA concentration. The exact structure of the hemichrome 
and which histidines (and possible methionine) are coordinating the heme cofactors is 
still unknown as in sw Mb (see Chapter 4). Unfortunately, these data and analyses are too 
preliminary to derive detailed structure conclusions about the nature of the hemichrome 
species; however there is no doubt that it exists reversibly during metHbA unfolding 
induced by GuHCl. 
7 A. Possible folding and assembly mechanism for holoHb 
A possible mechanism for Hb assembly is shown in Fig. 7.6 and is based in part 
on the broad apoHb unfolding curves, observed in our initial experiments and simulated 
by mechanism C in Fig. 7.1. In this more complex scheme, heme binding only occurs 
after the folded apoHb dimer is formed. However, as discussed in Chapter 4, studies of 
holoMb unfolding suggest that heme can bind non-specifically to folding intermediates 
and possibly to the completely unfolded state, albeit with a lower affinity than to the N or 
I folded states. If heme binding occurs to all species involved in the assembly of 
tetrameric hemoglobin formation, the complex eight-state mechanism shown in Fig. 7.6 
would apply. 
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Figure 7.6. Proposed mechanistic model for the assembly of HbA. In this scheme, we have assumed that 
folded apoHb is present as an al~1 dimer, and that this dimer is fonned via a dimer intermediate . We also 
assumed that the apoHbA dimer could potentially redimerize into a heterotetramer at high enough 
concentration , and that heme could bind to all apo states . A hemichrome state may be represented as the 
IDH2 species. The ribbon representations of the structures were created by Jayashree Soman using Ribbons 
and PDB entry: lird, for native holoHbA (TH4). The other structures were based on the folding of apoMb 
and are only for illustrative purposes. 
This mechanism requires a definition of the apoHb folding constants describing 
conversion of completely unfolded apo-subunits to apo-tetramers, plus heme binding to 
each of the four apoglobin states. Deriving the expressions for the folded species is much 
more difficult than for Mb, which only involves monomeric species, and requires finding 
roots of depressed quartic equations due to tetramer formation and heme dissociation, and 
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leads to a set of transcendental equations. The real situation may be even more complex if 
differences between the heme affinities and stabilities of the a and J3 subunits are large 
and if heme dimerization occurs. Thus, even the scheme in Fig. 7.6 is a simplification. 
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Figure 7.7. Proposed assembly mechanism for HbA. The mechanism was based on the assumptions that 
hemichrome species are dimeric globins as represented by IoH2 and that they are on path to assembly. 
Hemin would bind to the apo dimer intermediate, and in the cell reduction would induce folding and 
assembly to the native tetramer. 
The presence of a reversible hemichrome HbA species, induced by the presence 
of GuHCI, is of great value to the understanding of HbA assembly. If heme stays in the 
ferric form due to the presence of oxygen in the cytosol, the hemichrome species as 
identified in Fig. 7.4 could be on-path to assembly. Upon binding of the hemin cofactors 
to the globin chains, the reducing environment could induce rapid folding and formation 
of oxy and deoxyHb (Fe(II)) tetramers (Fig. 7.7). The newly discovered chaperone, alpha 
hemoglobin stabilizing protein (AHSP), aids in the assembly of Hb in the presence of 
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excess a-chains (Kihm et al., 2(02) and upon binding to the holo-a-chains, induces a 
hemichrome conformation (Feng et al., 2004; Feng et al., 2(05), reinforcing the idea that 
hemichrome species are on-path to assembly. However, the addition of AHSP adds 
another level of complexity to the assembly mechanism for HbA and would include 
folding steps for the a subunits alone. The assembly mechanism presented in Fig. 7.6 will 
require testing in future more quantitative analyses. 
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Chapter 8 
Conclusions 
In the past, the role of heme in the folding and assembly of globins remained 
elusive because of the lack of a quantitative theory to analyze observed unfolding curves. 
Most hemoglobin and myoglobin studies focused on the apoprotein without investigating 
how heme modulates the stability of the hologlobin. In this thesis, an analytical approach 
for interpreting the equilibrium-unfolding of monomeric hologlobins was derived and 
used to estimate the equilibrium constants for the dissociation of hemin from the globin 
folding states. This method requires systematic measurements of the unfolding of both 
apo- and holo-forms. To our knowledge, this combined analysis had never been done 
before, and the results in Chapters 4,5, and 6 provide strong evidence for the utility of 
this methodology for determining quantatively the effect of hemin binding on Mb 
stability. In theory, this approach is not limited to globins but applies to the study of all 
cofactor-containing proteins. 
The six-state mechanism presented in Chapter 4 (Fig. 4.3) was used to interpret 
the equilibrium-unfolding of five sw Mb variants and demonstrate that hemin binds 
specifically to the N apo state with very high affinity and to the apo molten globule 
intermediate (I) with moderate affinity ( .... 10-11 M). The discovery of the latter GuHCI-
induced hemichrome species, IH, during equilibrium-unfolding was unexpected. 
Hemichrome species have been the subject of great interest recently because 
hemichromes are present in the native states of several newly discovered hemoglobins, as 
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reviewed by Kakar et al. (2010). The hemichrome species in Mb is an equilibrium-
unfolding intennediate state with hemin coordinated most likely by two strong-field 
ligand side chains, including the proximal histidine (His93) and either the distal histidine 
(His64) or, in its absence, a nearby methionine (Met55) or histidine side chain. Another 
unexpected result is that GuHCI markedly induces hemin dissociation, increasing KNH, 
K1H, and KUH' and left-shifting the unfolding curves of the hologlobins. 
In Chapter 5, I was able to analyze semi-quantatively the effects of hemin 
dimerization and protein concentration on GuHCl-induced equilibrium-unfolding of WT 
and H97D sw holoMb. The addition of a free hemin dimerization step significantly 
increased the complexity of the analyses. As a result, fitting the unfolding curves at three 
different concentrations simultaneously was far more difficult than anticipated due to the 
large number of parameters needed to simulate the curves, and several of these 
parameters were undefined by the observed data. The reason for the lack of an observable 
protein concentration dependence of the GuHCI unfolding midpoint has been the subject 
of debate. My results suggest that the relatively strong binding of hemin to the I state to 
fonn the IH intennediate is the main factor. Our conclusions are built on the fact that the 
unfolding curves only show a strong protein concentration dependence during the later 
stage of unfolding, when hemin dissociation from the I state occurs, and reattachment to 
the unfolded U state is unlikely at these high [GuHCI]. The affinity of unfolded Mb for 
hemin in buffer is on the order of 1x1O·6 M when defined as a KUHO constant, and the 
presence of GuHCI weakens the affinity significantly as is observed for hemin binding to 
the N and I apoMb states. Contrary to our preliminary results with free hemin, our model 
suggests that GuHCI actually decreases free hemin dimerization at very high 
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concentrations of denaturant. Thus there is a build up and decay of this species, 
particularly at high total initial holoMb concentration. 
We also tested our analytical expressions with CerHb, a mini-globin which is 
lacking the A helix and does not appear to populate a folding intermediate in the apo 
form. The lack of an observable hemichrome species in CerHb supports our hypothesis 
that WT apoCerHb unfolds by a two-state mechanism and does not populate a folding 
intermediate. This result suggests that hemichrome formation in Mb requires a molten 
globule intermediate state in which the hemin pocket is partially or completely unfolded. 
In general, the level of recombinant expression of monomeric globins in E. coli 
appears to be correlated with the stability in the apo-form and hemin affinity. Thus it was 
initially surprising that CerHb expresses readily in E. coli despite low hemin affinity and 
stability in the folded apo-N state. However, unlike apoMb and particularly apoHb, the 
completely unfolded states of WT apoCerHb do not aggregate or precipitate rapidly at 
room temperature. Thus, even though apoCerHb unfolds more readily to the U state, it 
remains in solution, can readily refold in the presence of the cofactor, and then becomes 
more stable when the heme-iron is reduced. The cause of the increased solubility of the U 
state could be due to the smaller size of CerHb and its pI and charge distribution. 
In an effort to demonstrate the physiological relevance of our biophysical 
approach, I have correlated the GuHCl-induced unfolding parameters with the thermal 
stabilities of the proteins as measured empirically by their melting temperatures. Melting-
curves for apo- and hologlobin variants were monitored by the changes in ellipticity at 
222 nm as an indicator of secondary structure content. In contrast to GuHCI-induced 
unfolding, thermal unfolding of both apo- and hologlobins is not reversible; however, 
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measuring the midpoint of the thermal-unfolding transition still provides a good indicator 
of relative thermal stability when comparing variants. As hoped, the marked differences 
in resistance of the apoglobin variants to unfolding by GuHCI correlate well with changes 
in thermal stability, which also varied widely in both the apo- and holo-forms (Table 8.1). 
The correlations shown in panel B of Fig. 8.1 also demonstrate that the GuHCI midpoints 
for unfolding of the apoMb variants correlate well with the Gibbs free energy calculated 
using parameters derived from fits of the observed data for Mb variants and CerHb. 
Table 8.1. Comparison of thermal and chemical stability of apo- and hologlobins. 
Apo Holo 
Variant 
Tm (DC) [GuHClhl2 (M) Tm (DC) [GuHCl]1I2 (M) 
WTMb 63.9 1.35 84.6 1.77 
H64FMb 72.0 1.60 85.0 1.93 
T67PMb 48.9 0.78 74.7 1.05 
V68TMb 56.6 1.02 87.7 2.03 
H97DMb 65.7 1.25 72.5 1.20 
H64YN68FMb 72.5 n.d. n.d. n.d. 
WTCerHb 34.3 0.481 66.4 0.821 
NativeHbA <20 0.952 61.2 1.203 
The thermal midpoints were retrieved by fitting unfolding data induced by heat, monitored by CD at 222 
nm and using a two-state thermal-unfolding equation (Sanchez-Ruiz et aI., 1988). The GuHCl midpoints, 
[GuHClh/2' were obtained at half the CD signal at 222 nm for the holo variants, and at maximal 
fluorescence intensity for the apoMb variants. 
1 The [GUHC]112 for apo and holoCerHb were estimated using CD signals at 222 nm at 20DC in 100 mM 
phosphate pH 7. 
2 The [GuHC]1I2 for apoHbA was estimated using CD signals at 222 nm, at 40 14M apoHb concentration 
(on a subunit basis) in 100 mM phosphate pH 7 at 4 DC. 
3 The [GUHC]112 for native metHbA was estimated using CD signals at 222 nm, at 10 14M globin 
concentration (on a subunit basis), in 100 mM phosphate pH 7 at 20 DC. 
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Figure 8.1. Correlations between thermal and chemical stability of apo and hologlobin variants. The five 
Mb variants from Chapter 4 are represented with WT CerHb from Chapter 6. CerHb is only shown for 
illustrative purposes as the unfolding was done at lower temperature. The thermal stability is expressed as 
thermal midpoint, T m' and uses values from Table 8.1. The chemical stabilities are defined as the free 
energies of GuHCI-induced equilibrium unfolding (A and C), and as [GuHCI] transition midpoints (B and 
D). The values used are defined in Tables 8.1,4.2, and 4.4. ~GoFoldjng for the apoproteins was computed as-
RTln(KNloKIU~ and ~GFolding was computed as -RTln(KNHoKN/KIU~' 
The correlations for the holoMb variants and CerHb in panels C and D of Fig. 8.1 
also demonstrate that the resistance of these hologlobins can be expressed quantatively in 
terms of folding free energy (i.e., -RTln(KNHoKN/K/Ul)) derived from our mechanism and 
that the relative values represent the observed orders of stabilities measured empirically 
by midpoint [GuHCI] values. 
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HbA populates an 0 1131 dimer upon extraction of heme, which is on the path to 
assembly of HbA. Using a relatively simple theory, I evaluated three possible 
mechanisms for the formation of the apoHbA dimer. Preliminary data suggest that the 
apo-dimer folds via an apo-dimer intermediate; however we were not able to confirm our 
hypothesis due to experimental difficulties caused by the low stability and propensity for 
aggregation of apoHbA. Future analyses with more stable apoHb mutants should resolve 
the exact mechanism by which the 0 1131 apoHbA dimer assembles. 
It has been well documented that hemichrome species form during the 
denaturation of native HbA. Some of these hemichrome forms are found in vivo as red 
cell Heinz bodies. My results demonstrate that reversible hemichromes are also formed 
during equilibrium-unfolding of metHbA, and therefore are probably also on path for 
holoHbA assembly, which is much more complex. As a start, I have suggested an eight-
state mechanism for the equilibrium-unfolding of HbA (Fig. 7.6), in which Hb assembles 
via an apo-dimer intermediate that binds hemin to form a hemichrome species designated 
loH2 state. The spectral deconvolutions shown in Figs. 7.3-4 support this model and 
demonstrate that hemichromes are readily observable during holoHbA unfolding, and 
protein concentration dependence only occurs for the unfolding of hemichrome dimer 
species but not for that of the native holo-dimer state. Further studies are required to 
confirm our initial interpretations and to determine step by step the exact assembly 
mechanism for HbA as it occurs in vivo, with the addition of AHSP as a chaperone. 
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APPENDIX 
Derivations of equations and computer programs 
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A.1. Simple mechanism for monomeric globin unfolding 
K = [N][H] = K O exJ mNH[GUHCl]) 
NH [NH] NH 1 RT (A.l.l) 
K = [U] = K O exJ mNu[GUHCl]) 
NU [N] NU 1 RT (A.l.2) 
R =[NH]+[N]+[U] = [NH](l + KNH + KNHKNU ) 
o [ffi [ffi (A.l.3) 
[NH] = POYNH = Po[ K 1 K K 1 
l+~+ NH NU 
[H] [H] 
(A.lA) 
[H]=[N]+[U]=[mHb](KNH + KNHKNU )=Po 1 JKNH + KNHKNU ) [H] [H] 1 + KNH + KNHKNU [H] [H] 
[H] [H] 
(A.I .S) 
(A. 1.6) 
The population fractions of the three species can be obtained with the following 
equations: 
(A.I.7) 
(A.l.8) 
(A.I.9) 
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A.2. Simple mechanism for monomeric globin unfolding with hemin binding to the 
unfolded state 
K = [N][H] = K O exJ mNH[GUHCI]) 
NH [mHb] NH ~ RT (A.2.l) 
K = [U][H] = K O exJ muH[GUHCI]) 
UH [UH] UH ~ RT (A.2.2) 
K = [U] = K O exJ mNu[GUHCI]) 
NU [N] NU J!~ RT (A.2.3) 
(A.2 .4) 
[H] = [N] + [U] = [mHb]( K NH + K NHK NU ) 
[H] [H] 
(A.2.5) 
The concentration of hemin [H] is obtained using the following expression: 
(A.2.6) 
The population fractions of the three species can be obtained with the following 
equations: 
(A.2.7) 
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A.3. Simple mechanism for monomeric globin unfolding with hemin dimerization 
K = [N][H] = K O exJ mNH [GuHCI] ) 
NH [mHb] NH ~ RT 
K = [U] = K O exJ mNU [GUHCI]) 
NU [N] NU ~ RT 
K = [H2 ] = K O exJ mH 2 [GUHCI]) 
H 2 [H]2 H2 }'~ RT 
Po = [NH] +[N] +[U] = [NH](l + KNH + KNHKNU ) 
[H] [H] 
[N]+[U] = [NH](KNH + KNHKNU ) 
[H] [H] 
[H] + 2[H2] = [H] + 2K H 2 [Hf 
p,[ 1 JKNH + KNHKNU )=[H]+2KH [H]2 
o 1 + KNH + KNHKNU [H] [H] 2 
[H] [H] 
(A.3 .1) 
(A.3.2) 
(A.3.3) 
(A.3.4) 
(A.3.5) 
(A.3.6) 
(A.3.7) 
Equation A.3.7 can be rearranged into a cubic equation with the coefficients being: 
b = 1 + 2K H 2 (K NH + K NHK NU ) 
(A.3.8) 
(A.3.9) 
(A.3.10) 
(A.3.11) 
The appropriate root for [H] can be solved using Cardano' s method: 
[H]=-~ 
3a 
2b2 -9abc +27a2d +~(2b2 -9abc +27a2df -4(b2 - 3ac f 
3a 2 
Then the population fractions can be computed as in Appendix A.l: 
1 
YNH = ----------
1 KNH KNHKNU + --+ ---'-!.!..!....-.!..!.""'-[H] [H] 
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(A.3.12) 
(A.3.13) 
A.4. Three-state mechanism for the unfolding of apoMb 
The N-to-I and I-to-U transitions are defined according to: 
K = [I] = K O exJ mN1[GUHCI]) 
NI [N] NI 1 RT 
K - [U] _ KO (m/U[GUHCI]) /U - [I] - /U exp RT 
The concentrations of the I and U states are then defined as: 
[I] = [N]KNI 
The observable can be computed as: 
S S K o (mNI[GUHCI]) S KO K O 1 (mNI +m/U)[GUHCl]) N + I NI exp + U NI /U ex RT RT 
s-----------------------------~~----~----._~ 
- 1 K O (mN1[GUHCl]) K O K O j (mNI + m/U )[GUHCl]) 
+ NI exp RT + NI /Uex1 RT 
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(A.4.1) 
(A.4.2) 
(A.4.3) 
(A.4.4) 
(A.4.5) 
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A.5. Six-state unfolding mechanism or holoMb 
The dependence of [GuHCI] on the stability and dissociation constants is expressed as: 
K = [I] = KO exJ mN1[GUHCl]) 
NI [N] NI 1 RT 
K = [U] = K O ex (mlU[GUHCl]) 
IU [I] IU P RT 
K = [N][H] = K O ex.J mNH[GUHCl]) 
NH [NH] NH 1 RT 
K = [I][H] = K O exJ m/H[GUHCl]) 
IH [lH] /H p~ RT 
K = [U][H] = K O exJ muH[GUHCl]) 
UH [UH] UH 1 RT 
[H] = [N] + [I] + [U] 
Equation A.5.10 can be rearranged into a quadratic equation: 
a[H]2 + b[H] + c 
where: 
(1 KNHKNI KNHKN/KIU ) a= + + 
K/H KUH 
b = (KNH + KNHKN/ + KNHKN/KIU ) 
(A.5.l) 
(A.5 .2) 
(A.5.3) 
(A.5.4) 
(A.5.6) 
(A.5.7) 
(A.5.8) 
(A.5.9) 
(A.5.l0) 
(A.5.11) 
(A.5.l2) 
(A.5.13) 
The only possible solution for [H] is: 
The population fractions can be computed as in Appendix A. 
1 YNH =------------------------------------------
1 KNH KNHKN/ KNHKN/K/U KNHKN/ KNHKN/K/U + --- + + + + -..!..!.~~~ 
[H] [H] [H] K/H K UH 
ISO 
(A.S.14) 
(A.S.lS) 
(A.5.l6) 
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A.6. Six-state unfolding mechanism for holoMb with hemin dimerization 
U sing the same stability constants and hemin affmities in the six -state model, the hemin 
dimerization step is defined as: 
[N] +[I] +[U] = [H] +2[D] 
Equation A.6.4 can be rearranged into a cubic equation: 
a[H]3 + b[H]2 + c[H] + d 
where: 
a = 2K H2 (1 + KNHKN/ + KNHKN/KW ) 
K/H KUH 
The roots for this complex equation can be obtained using Cardano' s method. 
(A.6.1) 
(A.6.2) 
(A.6.3) 
(A.6.4) 
(A.6.5) 
(A.6.6) 
(A.6.7) 
(A.6.8) 
(A.6.9) 
A.7. Simple two-state process for the unfolding of the apoHb dimer 
The equilibrium folding constant is defined as: 
K = [D] =Ko exJ -mW,D[GUHCI]) 
W,D [U]2 W,D \ RT 
[D] = KW,D[U]2 
Po = 2[D] +[U] = 2Kw,D[U]2 +[U] 
The concentration of the unfolded state U is the root of a simple quadratic: 
-1+ ft+8PoKwD [U]= V , 
4KW,D 
The population fraction of the folded dimer is defined as: 
~ _ 2[D] 
D - 2[D]+[U] 
2K (-I+~1 +8PoKW,D)2 
W,D 4K W,D 
( -I+~1+8PoKW,D)2 (-I+~1+8PoKW'D) 2Kw D + ----=------'--, 4Kw ,D 4K2U ,D 
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CA.7.1) 
CA.7.2) 
(A.7.3) 
CA.7.4) 
(A.7.5) 
A.8. Unfolding of the apoHb dimer involving a first dissociation followed by 
unfolding of folded subunits, via an intermediate 
The equilibrium folding constants are defined as: 
K =!Q=Ko ex (-muJ[GUHCI]) 
U,I [U] UJ P RT 
K = [N] = K O exJ -ml,N[GUHCI]) 
I.N [l] I ,N p~ RT 
K = [D] = K O exJ -m2N ,D[GUHCI] ) 
2N,D [N]2 2N ,D 1 RT 
The concentration of each species is: 
[I] = Ku,l [U] 
[N] = K1,NKUJ[U] 
Solving equation A.8.7 for [U] leads to the following root: 
[U]- -(I + K/,NKUI + Kul ) +~(I + K/ ,NKUI + Kul )' + 8PoK2N,DK/,N 2Ku/ 
2 2 
4K2N,DKI.N Ku,I 
The population fractions can then be computed as: 
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(A.8.1) 
(A.8.2) 
(A.8.3) 
(A.8.4) 
(A.8.5) 
(A.8.6) 
(A.8.7) 
(A.8.8) 
(A.8.9) 
A.9. Unfolding of apoHb dimer involving a dimer intermediate 
The equilibrium folding constants are defined as: 
K = _U_D_1 = K O exJ_-m_ w...:...J o:;:....[_G_U_H_C_l1) 
W,lo [U12 2U,Io \ RT 
K __ [D_1 -Ko exJ -mlo ,D[GUHCl1) 
lo,D - U D] - 10 ,D I:'~ RT 
The concentration of each species is: 
[ID] = KWJo [uf 
[D] = KWJoKlo ,D[U12 
Solving equation A.9.7 for [U] leads to the following root: 
-1+ 11+8Po{Kwl KI D+KWJ ) [U] = V ' 0 o · 0 
4{K K +K ) W,/o lo .D W,/o 
The population fractions can then be computed as: 
Y
D 
= 2[D] 2KWJoKlo.D[u]2 
2[D] + 2[1 D] +[U] 2KWJoKlo,D[U]2 +2KWJo [U]2 +[U] 
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(A.9.1) 
(A.9.2) 
(A.9.3) 
(A.9.4) 
(A.9.5) 
(A.9.6) 
(A.9.7) 
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AIO. Code for simulation and fitting of the analysis of holoMb unfolding by a six-
state mechanism with heme dimerization 
#Code should be in a text file and run in Gnuplot 
#The data should be assembled into an excel sheet with the data gathered into a 
consecutive column. Column 1 should denote a reference to the protein concentration and 
detection method. For example, I used 2, 3, 10, 11, 100, 101 to denote the different data 
sets. Column 2 should be the [GuHCI] and the respective data should be arranged 
sequentially in Column 3. In order to create a multi plot for the normalized signals and 
population fractions, each data set was copied and arranged side by side in Columns 4 to 
9. Once the sheet was complete, the excel sheet was converted into a text file (Windows 
format, not MS-DOS) for Gnuplot to be able to read it. 
#This terminal should be used for working on the fits. However, the output only displays the fits but is not 
is not readable as a ps file. 
#set term xlI enhanced font "times,28" 
#set output 'WTfits.ps' 
#This terminal and output allows for very nice and readable figures 
set terminal postscript eps enhanced color 
set output "WTfitsforpub.eps" 
set title 'Equilibrium Unfolding of WT HoloMb' 
# Which protein concentration? 
#This equation allows for obtaining the protein concentration out of x 
P(x)=(floor(xlIOO»; 
# [GuHCI] Concentration 
#This equation allows for obtaining the [GuHCl] out of x. 
gc(x)=x-lOO*P(x); 
# Defining the dependence on [denaturant] 
knhv(x)=lmh*exp(mnh*gc(x)IRT); 
kihv(x)=kih*exp(mih*gc(x)IRT); 
kuhv(x)=kuh*exp(muh*gc(x)IRT); 
kniv(x)=kni*exp(mni*gc(x)IRT); 
kiuv(x)=kiu*exp(rniu*gc(x)IRT); 
kDv(x)=kD*exp(mD*gc(x)IRT); 
# Defining the cubic function with the abc d coefficients 
a(x) = 2.*kDv(x)*(l + knhv(x)*kniv(x)/kihv(x) + knhv(x)*kniv(x)*kiuv(x)lkuhv(x»; 
c(x) = knhv(x) + knhv(x)*kniv(x) + knhv(x)*kniv(x)*kiuv(x); 
b(x) = 2.*kDv(x)*c(x) + (I +knhv(x)*kniv(x)/kihv(x) + knhv(x)*kniv(x)*kiuv(x)lkuhv(x)); 
d2(x) = (-2e-6)*c(x); 
d lO(x) = (-1 Oe-6)*c(x); 
dlOO(x) = (-I00e-6)*c(x); 
#Changing to Monic 
A(x) = b(x)/a(x); 
B(x) = c(x)/a(x); 
C2(x) = d2(x)/a(x); 
CIO(x) = dIO(x)/a(x); 
ClOO(x) = dIOO(x)/a(x); 
#Solving the cubic and fmding the correct root 
Pea(x) = B(x) - A(x)**2/3.; 
Que2(x) = C2(x) + (2*A(x)**3 - 9*A(x)*B(x))/27 .; 
You2(x) = (-Que2(x)l2. + (Que2(x)**2/4. + Pea(x)**3127.)**(1.l2.»**(1.l3.); 
h2(x) = You2(x) - Pea(x)/(3.*You2(x» - A(x)/3 . 
QueIO(x) = ClO(x) + (2*A(x)**3 - 9*A(x)*B(x»/27.; 
You lO(x) = (-QueIO(x)/2. + (QuelO(x)**2/4. + Pea(x)**3 127.)**(1.12.»**(1.13.); 
hlO(x) = YoulO(x) - Pea(x)/(3.*YoulO(x» - A(x)/3. 
QuelOO(x) = ClOO(x) + (2*A(x)**3 - 9*A(x)*B(x»/27.; 
YoulOO(x) = (-QuelOO(x)/2. + (Que lOO(x) * *2 14. + Pea(x)**3 127.)**(1 J2.»**(1.l3.); 
hlOO(x) = YouIOO(x) - Pea(x)/(3.*YoulOO(x» - A(x)/3. 
# Partition Function 
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Q2(x)= 1 +knh v(x )/h2(x)+knhv( x)*kni v( x)1h2(x )+knhv(x )*kni v( x )*kiu v(x)1h2(x)+knhv( x) *kni v( x )lkihv( x) 
+knhv(x)*kniv(x)*kiuv(x)lkuhv(x); 
Q 1 O(x)= 1 +knhv(x)1h 1 O(x)+knhv(x)*kniv(x)1h 1 O(x)+knhv(x)*kniv(x)*kiuv(x)1h lO(x)+knhv(x)*kniv(x)lkih 
v(x)+knhv(x)*kniv(x)*kiuv(x)lkuhv(x); 
Q 1 OO(x)= 1 +knhv(x)1h 1 OO(x)+knhv(x)*kniv(x)1h 1 OO(x)+knhv(x)*kniv(x)*kiuv(x)1h IOO(x)+knhv(x)*kniv(x 
)Ildhv(x)+knhv(x)*kniv(x)*kiuv(x)lkuhv(x); 
# Defining the population fractions 
YNH2(x)= lIQ2(x); 
YIH2(x)=(knhv(x)*kniv(x)lkihv(x»/Q2(x); 
YUH2(x)=(knhv(x)*kniv(x)*kiuv(x)lkuhv(x»/Q2(x); 
YN2( x )=(knh v( x )1h2( x) )/Q2( x); 
YI2(x)=(knhv(x)*kniv(x)1h2(x»/Q2(x); 
YU2(x)=(knhv(x)*kniv(x)*kiuv(x)1h2(x»/Q2(x); 
YH2(x)=h2(x)/(2e-6); 
YD2(x)=2*kDv(x)*h2(x)*h2(x)l(2e-6); 
YNHI O(x)=lIQ 1 O(x); 
YIH 1 O(x)=(knhv(x)*kniv(x)lkihv(x»/Q 1 O(x); 
YUH 1 O(x)=(knhv(x)*kniv(x)*kiuv(x)lkuhv(x) )/Q 1 O(x); 
YNIO(x)=(knhv(x)IhIO(x»/QIO(x); 
YIIO(x)=(knhv(x)*kniv(x)IhIO(x»/QlO(x); 
YUIO(x)=(knhv(x)*kniv(x)*kiuv(x)lhl0(x»/QI0(x); 
YHlO(x)=hlO(x)/(10e-6); 
YDI0(x)=2*kDv(x)*hlO(x)*hIO(x)/(10e-6); 
YNH100(x)=lIQlOO(x); 
YIHl00(x)=(knhv(x)*kniv(x)lkihv(x»/QI00(x); 
YUH l00(x)=(knhv(x)*kniv(x)*kiuv(x)lkuhv(x»/Q 100(x); 
YNI OO(x)=(knhv(x)1h 100(x»/Q 1 OO(x); 
Yll OO(x)=(knhv(x)*kniv(x)1h 1 OO(x))/Q 1 OO(x); 
YU 1 OO(x)={knhv(x)*kni v(x)*kiuv(x)1h 1 OO(x) )/Q 1 OO(x); 
YHl00(x)=hl00(x)/(100e-6); 
YDI00(x)=2*kDv(x)*h1OO(x)*h1OO(x)/(lOOe-6); 
HInput of temperature 
TC=20; HTemperature in C 
T=TC+273.l5; HTemperature in Kelvin 
R=0.OO831447; H Ideal gas constant in kJ.mol-l.M-l K J 
RT=R*T; 
H Setting the observables 
SCDNH=O.9933; 
SCDN=O.6; 
SCDI=O.25; 
SCDIH=0.057 15; 
SCDU=O.0257; 
SCDUH=O.OI; 
SABSNH=1.01152; 
SABSIH=O.l881O; 
SABSUH=O.02; 
SABSH=O.152169; 
SABSD=O.451; 
H Defining the constants in buffer 
HNote that" .**" is the same as "e" for expressiong exponentials 
knh=7 .37e-14; H 
kih= 1 .18e-l1 ; H 
kuh=le-6; H (M) 
kni=I.6*10.**-2; 
kiu=l.1 * 10.**-2; 
kD=3.85e6; H 
H Defining the m values 
mnh=15.8171; HkJ.mol-l.M-l 
mih=13.4951; HkJ.mol-l.M-l 
muh=8.0; HkJ.mol-l.M-l 
mni=9.850; HkJ .mol-l.M-l 
miu=5.680; HkJ .mol-l.M-l 
mD=-4.8; HkJ .mol-l.M-l 
H Setting up the observables 
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ObsS2(x)= YNH2(x)*SABSNH+ YIH2(x)*SABSIH+ YUH2(x)*SABSUH+ YH2(x)*SABSH+ YD2(x)*SAB 
SD; 
ObsS 1O(x)= YNH 1O(x)*SABSNH+ YIH lO(x)*SABSIH+ YUH 1O(x)*SABSUH+ YH 1 O(x)*SABSH+ YD 1O( 
x)*SABSD; 
ObsS l00(x)= YNH100(x)*SABSNH+ YIH 1 OO(x)*SABSIH+ YUH 1 OO(x)*SABSUH+ YH l00(x)*SABSH+ 
YD 1 OO(x)*SABSD; 
ObsCD2(x)=YNH2(x)*SCDNH+ YIH2(x)*SCDIH+ YUH2(x)*SCDUH+ YN2(x)*SCDN+ YI2(x)*SCDI+ Y 
U2(x)*SCDU; 
ObsCD10(x)=YNHI0(x)*SCDNH+YIH10(x)*SCDIH+YUHI0(x)*SCDUH+YN10(x)*SCDN+YII0(x)*S 
CDI+ YU 1 O(x)*SCDU; 
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ObsCDI00(x)=YNHl00(x)*SCDNH+YIHl00(x)*SCDIH+YUHl00(x)*SCDUH+YNI00(x)*SCDN+YIl 
OO(x)*SCDI+ YUlOO(x)*SCDU; 
print "" 
print "******" 
print "Overall fitting showing dependence on protein concentration." 
print "******" 
print "" 
print "******" 
print "KNH= ", knh," / ", "KIH= ", kih," / ", "KUH= ", kuh," / ", "KH2= ", kD 
print "mNH= ", ronh," / ", "mlH= ", mih," / ", "mUH= ", muh," / ", "mH2= ", mD 
print "CDNH= ", SCDNH, " / ", "CDN= ", SCDN, " / ", "CDIH= ", SCDIH," / ", "CDI= ", SCDI, " 
", "CDUH= ", SCDUH," / ", "CDU= ", SCDU 
print "AbsNH= ", SABSNH," / ", "AbsIH= ", SABSIH," / ", "AbsUH= ", SABSUH," / ", "AbsH= ", 
SABSH," / ", "AbsH2= ", SABSD 
print "******" 
Observ(x) = \ 
(P(x)==2)?(ObsS2(x»:(P(x)==3)?(ObsCD2(x»:\ 
(P(x)== 1 O)?(ObsS 1 O(x»:(P(x)= 11 )?(ObsCD 1 O(x»:\ 
(P(x)==100)?(ObsSl00(x»:(ObsCDI00(x» 
HObsS(x) = (P(x)==2)?(ObsS2(x»:(P(x)== 1 O)?(ObsS 1 O(x»:(ObsS 1 OO(x»; 
HObsCD(x) = (P(x)==2)?(ObsCD2(x»:(P(x)=10)?(ObsCDI0(x»:(ObsCDI00(x»; 
HObsF(x) = (P(x)=2)?(ObsF2(x»:(P(x)=1O)?(ObsFlO(x»:(ObsFlOO(x»; 
#Overall fitting of data 
HFIT_MAXITER = 100 
HFIT _LIMIT = 1 e-9 
#fit Observ(x) "WTdat2.txt" using (100*$1+$2):3 via SABSIH,SCDIH 
HPlotting the fitting results with data 
set multiplot 
reset 
set samples 500 
set xrange [0:] 
set yrange [-0.05:1.2] 
set xlabel '[GuHCl] (M)' 
set ylabel'Nonnalized Signals' 
set size 0.48,0.5 
set origin 0.01 ,0.51 
set title "Nonnalized Signals" 
Hset key right bottom 
unset key 
plot \ 
'WTdat2.txt' using 2:4 with points pt 7 It 1, 'WTdat2.txt' using 2:5 with points pt 71t 3,\ 
'WTdat2.txt' using 2:6 with points pt 9 It 1, 'WTdat2.txt' using 2:7 with points pt 9 It 3,\ 
'WTdat2.txt' using 2:8 with points pt 5 It 1, 'WTdat2.txt' using 2:9 with points pt 5 It 3,\ 
ObsS2(x) with lines It 4 Ie 1 lw 4, ObsSlO(x) with lines It 2 Ie 11w 4, ObsSl00(x) with lines It -1 Ic 1 Iw 
2,\ 
ObsCD2(x) with lines It 4 Ie 3 Iw 4, ObsCDlO(x) with lines It 2 Ie 3 Iw 4, ObsCDlOO(x) with lines It -1 Ic 
3lw 2 
#plotting NH, IH, and UH 
set xrange [0:4] 
set yrange [-0.05:1.05] 
set xlabel '[GuHCI] (M)' 
set ylabel'Population Fractions' 
set origin 0.01 ,0.01 
set title "Population fractions" 
plot \ 
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YNH2(x) with lines It 4lc 7 lw 4, YNHlO(x) with lines It 2 Ie 7lw 4, YNHl00(x) with lines It -lIe 7 lw 2,\ 
YIH2(x) with lines It 4Ie 8 lw 4, YllIlO(x) with lines It 2Ie 8 lw 4, YllIl00(x) with lines It -1 Ie 8 lw 2,\ 
YUH2(x) with lines It 4Ie 3lw 4, YUHlO(x) with lines It 2Ie 3lw 4, YUHl00(x) with lines It -lIe 3 lw 2 
#plotting N, I, and U 
set xrange [0:4] 
set yrange [-0.05: 1.05] 
set xlabel '[GuHCI] (M)' 
set ylabel 'Population Fractions' 
set origin 0.51 ,0.51 
set title "Population fractions" 
plot \ 
YN2(x) with lines It 4Ie 9lw 4, YNlO(x) with lines It 2Ie 9lw 4, YNlOO(x) with lines It -1 Ie 9lw 2,\ 
YI2(x) with lines It 4 lc 2 Iw 4, YIlO(x) with lines It 2 Ie 2Iw 4, YIlOO(x) with lines It -lIe 2lw 2,\ 
YU2(x) with lines It 4Ie 1 Iw 4, YUlO(x) with lines It 2Ie 1 lw 4, YUlOO(x) with lines It -1 Ie 1 Iw 2 
#plotting H and D 
set xrange [0:4] 
set yrange [-0.05: 1.05] 
set xlabel '[GuHCI] (M)' 
set ylabel'Population Fractions' 
set origin 0.51,0.01 
set title "Population fractions" 
plot \ 
YD2(x) with lines It 4lc 7 lw 4, YDlO(x) with lines It 2lc 7 Iw 4, YDlOO(x) with lines It -1 Ie 7 Iw 2,\ 
YH2(x) with lines It 4Ie 9lw 4, YHlO(x) with lines It 2Ie 9Iw 4, YHI00(x) with lines It -llc 91w 2 
unset multiplot 
reset 
#to output fitting params to a text file 
set print 'fitparams.txt' 
print\ 
SABSNH,SABSIH,SABSH,SABSD,knh,kih,kuh,mnh,mih,muh,kD,mD,SCDNH,SCDN,SCDIH,SCDI,SC 
DUH,SCDU, 
unset print 
